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ABSTRACT 
We hypothesized that three types of kefir (Lifeway® Low Fat Strawberry Kefir, 
ProBugs Kefir, orange flavor, and Lifeway® Low Fat Plain Kefir) would have low glycemic 
index (GI), high insulinemic index (II) and high satiety index (SI). Secondarily, we 
hypothesized that there would be no significant correlations among postprandial satiety, 
glucose and insulin responses. Lastly, we hypothesized that kefir, like other dairy products, 
would have dissociation of GI and II. To test our hypotheses, this study was divided into 
three phases. In Phase I, a portion of Lifeway® Low Fat Strawberry Kefir (S group) and a 
portion of ProBugs Kefir, orange flavor (O group) containing 50 g of available carbohydrates 
were tested.  In Phase II, a portion of Lifeway® Low Fat Plain Kefir (P group) containing 25 
g of available carbohydrates were tested. In Phase III, 240-kcals portions of all three types of 
kefirs were tested. In all phases a single meal, randomized crossover design was performed in 
which the test meals were fed to 10 healthy, male and female adults. The total glucose AUC 
of S group (p< 0.0023), O group (p< 0.0002) and P group (p< 0.0002) were significantly 
lower compared with their respective glucose controls. A slight, but not significant inverse 
relationship between glycemic and satiety responses was observed with kefir beverages (r = -
0.87; P = 0.13). Using a variance of component analysis, it was found that in the future, a 
significant relationship between the correlated effects of the treatments on GI and SI can be 
further tested by increasing the number of subjects to 12. Like other dairy products, kefir 
showed a dissociation of GI and II.  Kefir can potentially be a useful food choice for patients 
with diabetes who are required to control their blood glucose levels.
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GENERAL INTRODUCTION  
Introduction 
 According to the World Health Organization (WHO), by 2015 an estimated 2.3 
billion adults will be overweight [Body Mass Index (BMI) of ≥ 25 kg/m2], and more than 
700 million will be obese (BMI of ≥ 30 kg/m2) (2008a). Obesity greatly affects the overall 
quality of life. It is the major contributor for chronic diseases such as: type 2 diabetes, 
cardiovascular disease, hypertension, strokes and some types of cancer (WHO/FAO, 1998; 
Wild et al., 2004; 2008a). When the per capita nutrient consumption in the United States, 
between 1909 and 1997 was compared with the prevalence of type 2 diabetes, Gross and 
colleagues observed a strong correlation between the consumption of refined carbohydrates 
and the prevalence of type 2 diabetes (Gross et al., 2004). Therefore, carbohydrates, in terms 
of both quantity and of quality, are receiving significant attention in current laboratory and 
clinical studies. 
 Glycemic index (GI) was first introduced by Jenkins and colleagues in 1981 to assess 
and classify different carbohydrate-rich foods according to their effects on postprandial 
glycemia (Jenkins et al., 1981). The original purpose of the GI was to provide additional 
information to help patients with diabetes to better control their blood glucose levels. Low-GI 
foods cause a smaller insulin response and a slower release of glucose into the bloodstream 
compared with high-GI foods. Later studies have shown that high-GI diets are independently 
associated with an increased risk of developing obesity, type 2 diabetes, cardiovascular 
disease, insulin resistance, and cancer (Livesey et al., 2008). As a result, a great deal of 
attention has been focused on the health benefits of consuming low-GI diets.  
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 Generally speaking, dairy products have low GI values. Based on the 2002 
International Table of Glycemic Index and Glycemic Load Values, four types of dairy 
products were tested for GI: ice cream, GI = 61 (regular, mean of five studies); milk, GI = 27 
(full-fat, mean of five studies); milk, GI = 32 (skim, one study); fermented milk, GI = 11 (3% 
fat, mean of two studies) and yogurt, GI = 14-38 (from lower value for non caloric sweetener 
to higher value for caloric sweetener, nonfat to low fat, range of 14 studies) (Foster-Powell et 
al., 2002). Our study is interested in kefir, the type of milk product that is commonly used in 
most Eastern Europe countries. Until the present time, no study has measured the GI of kefir. 
Today, kefir is becoming increasingly popular. Some researchers believe that the various 
health-promoting properties of kefir outweigh those of yogurt (Lopitz-Otsoa et al., 2006). 
With the increase of diabetes worldwide, it is worth examining if kefir can bring positive 
effects in helping to combat this pandemic disease.  
 Most of the foods tested for GI values have not been measured for their concurrent 
postprandial insulinemic responses. According to Del Prato et al. (1994), chronic, 
physiologic hyperinsulinemia can lead to the development of insulin resistance. Besides that, 
hyperinsulinemia is one of the risk factors in the development of many diseases, such as 
obesity, diabetes, cancer and dyslipidemia ((DeFronzo et al., 1991; Brouns et al., 2005).  
While the measurement of postprandial blood glucose responses is important, the 
measurement of postprandial insulinemic responses is equally important. The concept of 
insulin index (II) of foods generated by 1000-kJ (240-kcals) was developed by Holt et al. 
(1997) in order to systematically rate the postprandial insulinemic responses of different type 
of foods. II is calculated in the same fashion as the GI. The II of different type of kefir drinks 
will be measured in this study. 
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 In general, pure carbohydrates, sugars and starchy foods have a high correlation 
between glycemic and insulinemic responses (Lee et al., 1998). However, studies have 
shown that non-starchy foods can produce higher insulin responses than expected from their 
GI (Gannon et al., 1988; Holt et al., 1997; Ostman et al., 2001). This is because 
carbohydrates are not the only stimulus for insulin secretion. There are a number of 
insulinotropic factors that mediate postprandial insulin secretion including fructose, certain 
amino acids, fatty acids, and gastrointestinal hormones such as gastric inhibitory peptide, 
glucagon, and cholecystokinin (Nuttall et al., 1991; Morgan, 1992). Most recently, milk 
products were shown to elicit unexpectedly high insulin AUCs compared with the predicted 
insulin AUCs from their GI values (Ostman et al., 2001; Liljeberg et al., 2001). For example, 
in Ostman et al.’s study, they tested one type of regular milk and two types of fermented 
milk: ropy milk and filmjolk by using white bread as the standard. The GI values for all three 
milk products were very low, ranging from 12 to 30; however, the II values were very high 
relative to their GIs (reported to be similar with the reference meal’s value). Kefir is a kind of 
fermented milk product, which is somewhat similar with ropy milk and filmjolk. Therefore, 
the present study is interested in examining the relationship of GI and II of kefir and to 
further confirm the finding of Ostman et al., which is the dissociation of GI and II of dairy 
products.  
 Varied postprandial metabolic events elicited by high GI and low GI diets are 
hypothesized to have potential effects on satiety (Holt et al., 1995). Many studies have been 
conducted to examine the relationship between glycemic index and satiety. However, the 
results of the studies are inconsistent. Some found no effect of GI on satiety and food intake, 
while others found a significant suppression of hunger and appetite after consumption of the 
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low GI diets (Bornet et al., 2007). In 1995, Holt and colleagues saw the need for developing 
a system to produce a table that could demonstrate the energy-satiety ratio of a list of 
common foods; thus, introducing the concept of satiety index (SI) (Holt et al., 1995). Holt et 
al. believed that energy-equivalent loads of the different nutrients can have different effects 
of satiety, thermogenesis, carbohydrate storage and fat storage. Even though a number of 
studies have shown different types of nutrients and foods satisfy hunger to varying extents, 
we still have a limited understanding of the complex interacting mechanisms of satiation 
(Holt et al., 1995). One purpose of the present study is to measure the satiety index of kefir 
drinks. We are interested in knowing the SI score (%) of kefir compared with the list of 38 
foods tested by Holt et al. on an isoenergetic basis. Moreover, in a later publication, Holt et 
al. used the SI scores (%) of 38 foods to determine whether the postprandial increments in 
subjective satiety, plasma glucose and insulin responses were interrelated (Holt et al., 1996). 
This is because Holt and colleagues believed that postprandial increments in plasma glucose 
and/or insulin are likely to be among the physiological mechanisms responsible for the 
satiating effects of foods. Therefore, our study is also designed to determine the 
interrelationships among postprandial satiety, glucose and insulin responses. 
In summary, the objectives of this study were: 1. Determine the glycemic, 
insulinemic and satiety indexes of three types of kefir (Lifeway® Low Fat Strawberry Kefir, 
ProBugs kefir, orange flavor, and Lifeway® Low Fat Plain Kefir); 2. Determine the 
interrelationship among postprandial satiety, glucose and insulin responses; 3. Examine the 
relationship of GI and II of kefir to further confirm the dissociation of GI and II of dairy 
products.  
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Thesis Organization 
 This thesis contains a general introduction, a literature review focusing mainly on 
glycemic index (GI), insulinemic index (II) and satiety index (SI). Kefir-yogurt-like 
fermented milk product was discussed briefly in the literature review. The paper entitled 
“Effects of kefirs on glycemic, insulinemic and satiety responses” will be submitted to 
British Journal of Nutrition. A general conclusion is included following the paper. 
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LITERATURE REVIEW  
Obesity and Diabetes in United States 
According to the World Health Organization (WHO), by 2015 an estimated 2.3 
billion adults will be overweight [Body Mass Index (BMI) of ≥ 25 kg/m2], and more than 
700 million will be obese (BMI of ≥ 30 kg/m2) (2008a). The high prevalence of being obese 
and overweight mostly exists in developed countries with the United States as one of the 
most severe. 65% of adults in the United States are overweight and 30% are obese (Muoio et 
al., 2006). Obesity greatly affects the overall quality of life. It is the major contributor for 
some chronic diseases, for example type 2 diabetes, cardiovascular disease, hypertension, 
stroke and some types of cancer (WHO/FAO, 1998; Wild et al., 2004; 2008a). Among these 
diseases, type 2 diabetes has the highest correlation with obesity. 90 % of the type 2 diabetes 
cases in western countries are due to overweight or obesity (2008b). According to the 
Centers for Disease Control and Prevention, there was a 765% increase in type 2 diabetes 
cases from the year 1935 to 1996 (Gross et al., 2004). WHO projects in the next 10 years 
there will be a 50% increase in diabetes deaths worldwide (2008a).  
 Inevitably, genetic predisposition plays a role in causing obesity and type 2 diabetes; 
however, we can not deny the fact that sedentary lifestyles and the increased availability of 
energy-dense, micronutrient-poor foods, promote these conditions in most industrial 
countries (Perusse et al., 2000; Aguilar-Salinas et al., 2005). Among all the macronutrients, 
dietary fat has been thought to be an important determinant of body fat, and several 
mechanisms have been proposed (Van Amelsfort, 1989; Astrup et al., 1993, 1994, 1995). As 
a result, for the prevention and treatment of diabetes, American Diabetes Association (ADA) 
guidelines emphasize controlling dietary fat in terms of source and amount (2008c). The 
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World Health Organization also promotes the minimum intake of fats and advocates the shift 
of saturated fat to unsaturated fat (2008a). However, does this approach (reduce the intake of 
dietary fat) work in stopping the rapid increase of obesity and type 2 diabetes?  Although the 
percent of energy consumed from fat has decreased from 42 to 34%, the prevalence of 
overweight and obese has risen tremendously over the last three decades in the United States 
(Ludwig, 2000). In 2003, Pirozzo reviewed six different long-term studies on low-fat diets in 
controlling weight gain (Pirozzo et al., 2003). A total of 594 overweight or obese subjects 
participated in these six trials. The duration of the intervention varied from 3 to 18 months 
with 6 to 18 months of follow-up. His review shows that low-fat diets could not sustain 
weight loss in obese or overweight people. Therefore, these findings suggest that factors 
other than dietary fat cause the rapid increase of obesity rate.  
Gross and colleagues showed that more calories are now obtained from carbohydrates 
to compensate for the low-fat food intake (Gross et al., 2004). Gross and colleagues 
examined the correlation between the consumption of refined carbohydrates and the 
prevalence of type 2 diabetes in the United States. In this study, the per capita nutrient 
consumption in the United States between 1909 and 1997 obtained from the United States 
Department of Agriculture was compared with the prevalence of type 2 diabetes obtained 
from the Centers for Disease Control and Prevention. In a multivariate nutrient-density 
model, the results showed that there is a strong correlation between the consumption of 
refined carbohydrates and the prevalence of type 2 diabetes in United States. Therefore, 
carbohydrate in terms of both quantity and quality is receiving significant attention in the 
current scientific and clinical studies. Some well-established scientists believe it is the 
8 
increased intake of carbohydrate that causes the ever-increasing rate of obesity and type 2 
diabetes (Ludwig, 2000; Pawlak et al., 2002; Brand-Miller et al., 2002). 
Carbohydrate is the most common source of energy. It is the easiest macronutrient to 
be absorbed by human body compared with protein and fat. The current focus on 
carbohydrate is how it can affect postprandial blood glucose. One method that has been 
developed to rank carbohydrate-rich foods based on their physiological effect is glycemic 
index (GI) or glycemic load (GL). 
Glycemic Index 
A) The development of glycemic index 
 Glycemic index (GI) was first introduced by Jenkins and colleagues in 1981 to assess 
and classify different carbohydrate- rich foods according to their effect on postprandial 
glycemia (Jenkins et al., 1981). This concept was developed to better understand the 
physiological responses of carbohydrate in the diet. However, before this concept was 
introduced, carbohydrates in foods were defined as available or unavailable for humans 
based on their chemical structures (Southgate, 1976). Chemical structures of available 
carbohydrate are for example, those in the disaccharides (maltose, sucrose, and lactose), α-
1,4 linkages of amylase, α-1,4 and α-1,6 linkages of amylopectin; whereas chemical structure 
of unavailable carbohydrate includes β-1,4 linkages of fiber such as, cellulose, 
hemicelluloses and pectin. In other words, the available carbohydrate foods for humans are 
those that can be absorbed by the small intestine and the unavailable carbohydrate foods are 
foods that can not be absorbed by the small intestine. It was believed that all available 
carbohydrates in all foods were biologically equivalent. Therefore, in 1950, in order to help 
patients with diabetes manage their diets, the American Dietetic Association, the American 
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Diabetes Association, and the U.S. Public Health Service developed a food exchange list 
(Caso, 1950; Laine et al., 1987). In the exchange list, foods that are alike are grouped 
together. Foods on each list have approximately the same amount of carbohydrate, protein, 
fat and calories. All the choices on each list are equal; therefore, any food on the list can be 
exchanged for any other food on the same list. There are three main groups in the list: 
carbohydrate group; meat and meat substitute group; and fat group.  
Later, in the 1970s, multiple research studies showed that not all the available 
carbohydrates in foods gave the same physiological responses. In a series of studies, Crapo 
and colleagues tested postprandial blood glucose and insulin responses to different types of 
simple and complex carbohydrates. Their results showed that postprandial blood glucose and 
insulin responses were not the same for a standard weight of carbohydrate in different 
carbohydrate-containing foods (Crapo et al. 1976, 1977, 1980, 1981). For example in one 
study, 50 g carbohydrate in dextrose, rice, potato, corn and bread were tested in 16 normal 
healthy subjects in a randomized crossover study design. The results showed that dextrose 
and potato elicited similar and greater plasma glucose and insulin responses compared with 
rice, corn and bread. Besides that, Jenkins and colleagues believed that the food exchange list 
used by many patients with diabetes may not reflect the physiological effect of foods. 
Therefore, in 1981, they developed a standard procedure to measure the glycemic response of 
different foods by comparing a reference meal with a glucose solution (see Methodology of 
GI below). They published the first glycemic index list of 62 commonly eaten foods (Jenkins 
et al., 1981). They used this GI food list to supplement information in food tables. They 
believed their finding could help patients with diabetes to better control their postprandial 
blood glucose. 
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Table 1: Glycemic index of selected foods (adapted from Jenkins et al., 1981) 
Food       
GI Glucose = 
100       
Bread (white)    69       
Rice (white)    72       
Spaghetti (white)    50       
Sweetcorn     59       
All‐Bran      51       
Cornflakes    80       
Carrots      92       
Potato (instant)    80       
Beans (kidney)    29       
Lentils      29       
Banana      62       
Raisins      64       
Ice cream      36       
Milk (whole)     34          
 
B) Methodology of GI 
 Glycemic index is defined as the incremental area under the blood glucose response 
curve (IAUC) after the consumption of 50 g available carbohydrates in a meal divided by the 
incremental area under the curve of 50 g available carbohydrates in a reference meal, which 
is a glucose solution which is sometimes replaced by 50 g glucose equivalent of white bread 
(Wolever, 1991).  
 
Incremental blood glucose area 
of test food 
 
Incremental blood glucose area of 
reference food 
 
×  100 GI  =   
11 
 In order to obtain the greatest precision in GI values, the variation among subjects is 
recommended to be minimized. Usually, only healthy subjects are recruited for GI test. It is 
believed that the subjects’ physiological condition, for example insulin sensitivity and 
glucose tolerance status, could influence the glycemic response to food (Brouns, 2005). 
Therefore, individuals with type 1 or 2 diabetes, or individuals who are glucose intolerant are 
excluded. No tobacco use is another exclusion criterion. This is because tobacco may cause 
acute insulin resistance (Attvall et al., 1993; Frati et al., 1996). 
 The day before the GI test, subjects are advised to refrain from vigorous physical 
activity. According to Mikines et al. (1988), vigorous exercise prior to the test can improve 
insulin sensitivity by increasing muscle glucose uptake. In their study, seven healthy 
untrained young men were recruited to go through four sequential euglycemic 
hyperinsulinemic clamps after rest (R), immediately after exercise (E) and 48 h after 60 min 
of 150 W ergometer exercise (ER). The data demonstrated that the insulin-mediated glucose 
uptake was higher on E and ER days compared with R days. The GI test is recommended to 
be done in the morning (at breakfast time) after 10- 14 hours of fasting. According to Brouns 
(2005), this fasted condition is the most stable condition of the subjects because meal 
influences (breakfast meal) can be avoided in the test. In Wolever & Bolognesi’s study, there 
was a significant difference in the glycemic response to cereals when tested in the morning 
and at lunchtime (Wolever & Bolognesi, 1996).   
 On the day of the meal tolerance test, a portion of food containing 50 g of available 
carbohydrate (total carbohydrate minus dietary fiber) is recommended to be given to the 
subjects. However, some foods have a low to moderate amount of carbohydrate per serving. 
Therefore to avoid an unrealistically large serving of low carbohydrate density food, 25 g of 
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available carbohydrate portion is allowed with a corresponding 25 g of reference meal 
(Brouns, 2005). One example of food with very low carbohydrate is carrot (5.1 g of available 
carbohydrate per 72 g) (Pennington, 1998). In order to get 50 g of carbohydrate, 
approximately 706 g of carrots would be required to be ingested by the subjects. Therefore it 
is a very unrealistic portion size, which the subjects would not be able to finish in a short 
amount of time (15 minute time limit). In this case 25 g of carbohydrate load is permitted to 
apply for GI test of carrots, but at the same time, the reference meal has to be reduced to 25 g 
of carbohydrate. Data have shown a range of 25 to 50 g of available carbohydrate is suitable 
for GI testing. Available carbohydrate of less than 25 g might be considered for foods that 
have very low available carbohydrate content, but it is not recommended. This is because so 
far not many GI studies were conducted with less than 25 g of available carbohydrate; 
therefore the results are difficult to compare (Brouns, 2005). 
 To date, more than 90% of the GI tests were done by using glucose or white bread as 
the reference meal (Foster-Powell et al., 2002). The original work of Jenkins was using 50-g 
of glucose solution as the standard reference meal. However, throughout the course of GI 
development, some researches prefer white bread over glucose drink. The excessive 
sweetness of the glucose drink can bring nausea to the subjects. In 1982, Thompson et al. 
showed that the glucose solution has high osmotic effect; hence it may delay gastric 
emptying (Thompson et al., 1982). Glucose and white bread do not have the same glycemic 
response (GI glucose = 100; GI white bread = 70). Therefore, in order to convert from 
glucose to white bread as the reference meal, the GI value has to be multiplied by 1.4 (Food 
and Agriculture Organization, 1998). GI values using glucose and white bread correlate very 
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well (r = 0.98) (Wolever et al., 1991). When compare GI food values, it is advised to know 
the reference meal used. 
 When subjects are given the test or reference meal, they are required to finish the 
meal within 5- 10 min for liquid food and 10- 20 min for solid food (Brouns, 2005). Jenkins 
et al. demonstrated that prolonging the time of ingestion from a few minutes to several hours 
has a huge impact on glycemic responses on both liquid and solid food (Jenkins et al., 1990). 
When the rate of ingestion is decreased, the release of hormones such as gastric inhibitory 
polypeptide and insulin is reduced. This delay of hormones secretion reduces the rate of 
nutrient delivery to the body, in this case glucose. A baseline blood sample is obtained by 
capillary finger-stick before the subjects have their meal. After their first sip/bite of the meal, 
subjects resume fasting and subsequent capillary finger-stick blood samples are obtained at 
15, 30, 45, 60, 90 and 120 min for normal, healthy subjects and 15, 30, 45, 60, 90, 120, 150, 
180 min for patients with diabetes (Brouns, 2005).  
 The method of blood sampling in GI test plays a crucial role in measuring the 
postprandial glycemic response. Arterial blood is the most ideal source of blood sample. 
However, it is risky and invasive to obtain arterial blood and as a result, capillary blood is 
used in most of the GI studies. Venous sampling was used in some of the GI studies, but 
venous and capillary blood show significant differences in postprandial glycemic response. 
This is because the tissues consume glucose; therefore the glucose concentration in 
peripheral vein is lower than that in artery (Brouns, 2005). Also, it has been confirmed that 
venous glucose measurement provides more variation than did the capillary blood. In an 
interlaboratory study, GI values of four centrally provided foods (instant potato, rice, 
spaghetti and barley) and locally obtained white bread were tested in 8- 12 individuals in 
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each of seven centers using the method recommended by FAO/WHO. The results showed 
that the standard deviation (s.d.) of center mean GI values was significantly reduced from 
10.6 (range 6.8- 12.8) to 9.0 (range 4.8- 12.6) when venous blood data was excluded 
(Wolever et al. 2003).  
In terms of the area under the curve (AUC) calculation, there are several methods. 
The methods which are mostly used (Brouns, 2005) include: 
1) Total AUC; 
2) Incremental area until first return to baseline  
3) The area over the baseline under the curve, ignoring area beneath the baseline; 
4) Incremental area using the lowest blood glucose as the baseline; 
5) The net incremental AUC (apply trapezoid rule for all increments positive and 
negative) 
However, the method recommended by the Food and Agriculture Organization 
(1998) is the incremental AUC (method 4) (Brouns, 2005). This method does not take into 
account the area under the fasting concentration, which is zero time point. This is the most 
widely used method by most of the researchers including the founder of GI concept, Jenkins. 
When interpreting the results of different GI studies, it is necessary to determine the method 
used by the authors. This is because GI results do not agree with each other among some of 
the methods (Brouns, 2005). 
When calculating GI, individual IAUC of reference food was advised to be used 
instead of the average IAUC reference food of a group. This is because overall glycemic 
response in the blood circulation is the sum of net entry of exogenous glucose from the portal 
vein and endogenous glucose from hepatic output, and net removal of glucose by tissues 
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(Englyst et al., 2005). Due to biological variation in hepatic glucose output and tissue glucose 
uptake among individuals, postprandial glycemic responses can be very different from one 
subject to another.  
C) Glycemic Load 
The GI value predicts the blood glucose response after the consumption of a typical 
50 g available carbohydrate of a food, but it does not tell us the serving size of this amount of 
carbohydrate. On the other words, GI values provide a measure of carbohydrate quality of 
food but not the quantity (Foster-Powell et al., 2002). Therefore, in 1997, the concept of 
glycemic load (GL) was introduced (Salmeron et al., 1997a; Salmeron et al., 1997b). GL is 
used to quantify the overall glycemic effect of a serving of food.  
 
High GI food does not always have a high GL value. Let’s take a carrot as an example. 
Carrot has a high GI value (GI=131). However a 3 oz serving of carrot is small (GL=11.8). 
This is because carrot is not a high carbohydrate food. There is only 9 g of carbohydrate in 3 
oz carrot. As a result, patients with diabetes should not solely refer to GI values of food to 
make their food choices. In the revised international table of glycemic index, the GL of food 
per serving is listed (Foster-Powell et al., 2002).  
 
the amount of available carbohydrate 
contained in a specified serving size of the 
food  
 
100 
GI   × GL  =   
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Table 2: Glycemic Load of selected foods (adapted from Foster‐Powell et al., 2002)    
Food        GI Glucose = 100    
Available CHO 
(g/serving)       GL 
Croissant      67    26      17 
Cranberry juice drink  56    29      16 
Gatorade      78    15      12 
Baguette (white, plain)  95    15      15 
All‐Bran      51    23      9 
Special K      69    21      14 
Rice (white)    69    43      30 
Milk (skim)    32    13      4 
Apple      40    16      6 
Beans, dried     36     30        11 
 
D) Implications of GI on health 
 The rate of glucose being released into the bloodstream and the duration of the rise in 
postprandial blood glucose levels is known to cause many hormonal and metabolic changes 
that could affect health and disease parameters (Brouns et al., 2005). A recent systematic 
review and meta-analysis by Livesey and colleagues (2008) showed reduced risk markers 
related to persons who are overweight, obese, diabetic or at risk of coronary heart disease 
when low GI/GL diets were used in the intervention. This meta-analysis was done by 
collecting data from 45 controlled dietary intervention trials on GI reported in the literature 
before January 2005. There were 972 subjects per treatment arm of all ages (study group 
mean ages 10 to 63 y) with both males (511) and females (461). Several observational 
studies, clinical trials, meta-analyses and mechanistic studies in animal models also showed 
that diets with high GI/GL are independently associated with increased risks of developing 
obesity, type 2 diabetes, and cardiovascular disease. The following thesis will discuss some 
of these studies and how the use of low GI/GL diets has brought improvement to those 
diseases. 
17 
a) Weight management and obesity 
Tremendous emphasis has given to the reduction of dietary fat intake when it comes to 
the prevention and management of overweight and obesity. However, low-fat diets may help 
with short-term weight loss, but not with long-term effectiveness. This is shown by the 
Women’s Health Trial Feasibility Study done by Sheppard and colleagues (Sheppard et al., 
1991). 303 women who were ≤ 150% of their ideal weight were enrolled in this study and 
assigned to either the low-fat diet group (fat intake = 22% of energy) or control group (fat 
intake = 39% of energy). The results demonstrated that women in the low-fat diet group lost 
3.2 kg of body weight by six months, but by 24 months some of this was regained and they 
had lost only 1.9 kg. Consequently, the weight difference between the treatment group and 
control group after one year was 1.8 kg, which was not significantly different. The reason 
why low-fat diets are not sustainable are because overweight and obese individuals after 
losing weight may experience increased hunger (Doucet et al., 2000), decreased resting 
energy expenditure (Astrup et al., 1999) and decreased fat oxidation (Filozof, 2000). As fat 
intake is decreased, there is a parallel increase in dietary high GI carbohydrate intake. The 
GI/GL of the average diet in the United States has been increasing during the past century, 
especially during the past 20 years based on an ecologic correlation study done by Gross and 
colleagues when they examined the per capita nutrient consumption in the United States 
between 1909 and 1997 (Gross et al., 2004). An observational study by Ma et al. revealed 
that BMI is positively associated with the dietary GI of 572 healthy adults in central 
Massachusetts. In this study, the average body mass index was 27.4 kg/m² (standard 
deviation 5.5) and the mean daily dietary glycemic index was 81.7 (standard deviation, 5.5) 
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(Ma et al., 2005). Many research studies are looking into the relationship of glycemic index 
with weight management. 
Brand-Miller, a researcher who is an advocate of low GI diets, hypothesized that high-
GI foods stimulate carbohydrate oxidation and suppress fat oxidation in the postprandial 
period. This alteration of fuel partitioning hence causes body fat gain (Brand-Miller et al., 
2002). Her hypothesis was supported by randomized, controlled, multicenter intervention 
studies comparing the effects of conventional and low-GI diets on weight control. Ludwig 
(2002) delineated the mechanism behind Brand-Miller’s hypothesis by evaluating animal 
studies, human intervention studies and epidemiological studies that examine the relevance 
of glycemic index for pathophysiological mechanisms affecting body-weight regulation, 
diabetes, and cardiovascular disease. When a high GI meal is consumed, the glucose released 
from the meal is rapidly absorbed by the body. A sudden increase of glucose into the 
bloodstream causes hyperglycemia, which then stimulates insulin release from pancreatic 
beta cells and inhibits glucagon release from alpha cells. When the ratio of insulin-to-
glucagon is high, according to Ludwig, it can alter the normal anabolic responses to food 
consumption. He believes this condition provokes glycogenesis and lipogenesis, and it 
suppresses gluconeogenesis and lipolysis. A recent study by Clapp and Lope supported 
Ludwig’s rationale (Clapp et al., 2007). In this study, after twenty days of low GI diets 
compared with high GI diets consumption, seven healthy adult women’s caloric requirements 
were 11% higher, fat oxidation at fasted rest was 27% higher and glucose as well as insulin 
levels were approximately 40% lower. Ludwig’s own study also showed the circulating 
levels of fatty acids were lower after consuming high-GI test meals compared with low and 
medium-GI meals when tested on 12 obese (mean weight 106.6±22.3 kg and height 
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1.68±0.09 m) teenage boys on three separate occasions using a crossover study protocol 
(Ludwig et al., 1999). Long-term studies, using animals as models, also demonstrated high-
GI diets increased the expression of lipogenic enzymes (fatty-acid synthase) (Kabir et al., 
1998) thus increasing lipogenesis. 
Based on the glucostatic theory of food intake regulation introduced by Meyer, low 
blood glucose is one of the metabolic signals for hunger (Mayer, 1953). However, later 
studies showed it is the transient declines in blood glucose rather than the absolute blood 
glucose concentration that gives a signal to glucostatic receptors in the central nervous 
system that fuel is low and the body needs to be replenished (Louis-Sylvestre et al., 1980; 
Smith et al., 1993; Campfield et al., 1990). A study done by Melanson et al. showed that the 
more rapid the decline in blood glucose following a meal-induced peak, the higher the 
hunger ratings (Melanson et al., 1999). Therefore insulin-induced hypoglycemia caused by 
high-GI food consumption can encourage over-eating and hence promote weight gain as the 
body homeostatic system attempts to restore energy. Stephan and colleagues’ research 
showed that postprandial hypoglycemia is very pronounced in obese subjects (Stephan et al., 
1972). An opposite phenomenon is observed with low GI-foods. Many short-term studies 
have shown low-GI foods minimize postprandial insulin secretion, promote satiety and 
therefore lower subsequent voluntary food intake (Ludwig, 2000; Roberts, 2000; Pawlak et 
al., 2002; Brand-Miller et al., 2007). A review article written by Roberts concluded that there 
is an average of 29% more energy intake after consumption of high-GI meals than low-GI 
meals (Roberts, 2000). For example, 12 obese (mean weight = 106.6±22.3 kg and height = 
1.68±0.09 m) teenage boys were given instant oatmeal (high-GI food) and steel-cut oats 
(low-GI food) with identical energy and macronutrient content at breakfast and lunch. 
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Throughout the afternoon, ad libitum food intake was monitored. Energy intake was 53% 
higher for the high-GI group compared with the low-GI one (Ludwig et al., 1999).  
b) Diabetes 
The original purpose of GI was to supplement the existing carbohydrate exchange list 
used by people with diabetes in meal planning, so that the patients could have an appropriate 
intake of glucose according to their physiological requirement (Jenkins DJ et al., 1981). 
However, Gilbertson’s group suggested that low-GI dietary approach could provide a better 
quality of life for patients with type 1 diabetes compared with carbohydrate exchange dietary 
approach (Gilbertson et al., 2001). In this study, 104 children with type 1 diabetes were 
recruited and HbA1c levels, incidence of hypo- and hyperglycemia, insulin dose, dietary 
intake, and measures of quality of life by a quality-of-life questionnaire completed 
independently by the parent and child were collected. The results of this study also showed 
that the flexible low-GI dietary regimen could improve HbA1c (glycosylated hemoglobin) 
levels without increasing the risk of hypoglycemia. Numerous epidemiological studies 
suggest that low GI/GL diets may play a role in the prevention and treatment of type 1 
(Buyken et al., 2001) and type 2 diabetes (Salmeron et al., 1997a; Salmeron et al., 1997b). 
Low GI diets can help by improving the glycemic control (Brand-Miller et al., 2003b) and 
reducing demand on the pancreatic beta cell in the post-prandial period (Pawlak et al., 2002). 
This is proven by several intervention studies. In Jenkins and colleagues’ study, six healthy 
male subjects underwent 2-weeks of metabolically controlled high-GI diets and 2-weeks of 
low-GI diets in random order (Jenkins et al., 1987). During the 2-week low GI diets, subjects 
showed significant reductions in serum fructosamine (a marker of glucose concentration) and 
urinary C-peptide (a marker of insulin secretion). These markers showed that low-GI diets 
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elicited lower concentrations of glucose and insulin. A randomized crossover study by Jarvi 
and colleagues showed that patients with type 2 diabetes who consumed low-GI diet had a 
30% lower plasma glucose and insulin compared with a high-GI diet (Jarvi et al., 1999). 
Giacco and colleague’s study demonstrated that 63 subjects with type 1 diabetes, aged 28 +/- 
9 years, and BMI of 24 +/- 0.6 kg/m2 who consume low-GI diet for 24 weeks had a decrease 
mean of daily blood glucose concentrations and number of hypoglycemic events (Giacco et 
al., 2000). In addition, low GI diets can help with increased insulin sensitivity (Pawlak et al., 
2002; Brand-Miller et al., 2008; Livesey et al., 2008). A randomized crossover, high versus 
low-GI study done by Clapp and Lopez showed that various indices of insulin sensitivity 
were more than 20% higher in the group of consuming low-GI diets when tested on seven 
healthy nonpregnant women (Clapp et al., 2007). More recently, Ma et al. conducted a 
randomized clinical trial comparing low-GI versus ADA dietary education among 40 
individuals (BMI= 35.8 kg/m²) with poorly controlled type 2 diabetes (Ma et al., 2008). This 
study consisted of eight educational sessions focusing on a low-GI or and ADA diet. After 12 
months of intervention, patients in low-GI diet group had a reduction in the use of diabetic 
medication but achieved equal control of HbA1c and blood lipids with the ADA diet group.   
c) Cardiovascular disease (CVD) 
High level of postprandial blood glucose after the consumption of high-GI diet may 
affect risk for cardiovascular disease. For example, a study done in the Hoorn population 
(3553 men and women aged 50-75 years in a small town in the Netherlands) showed that 
there was a significant relationship between the eight-year risk cardiovascular death and two-
hour post-load blood glucose concentrations in subjects with normal fasting glucose 
concentration after adjustment for known risk factors (DeVegt et al., 1999). During 20 years 
22 
of follow-up, 1994 new cases of cardiovascular disease were documented among 82,802 
women in the Nurses’ Health Study by using food-frequency questionnaires as the 
assessment of diet and glycemic load (Halton et al., 2006). Among all these cases, a higher 
glycemic load, but not protein or fat intake, was strongly associated with an increased risk of 
cardiovascular disease (relative risk of 1.9 comparing highest and lowest quintiles of GI) 
after multivariate adjustment. Hyperinsulinemia, which is caused by hyperglycemia with the 
presence of insulin resistance, is associated with dyslipidemia (high very low-density 
lipoprotein [VLDL] cholesterol, high triglycerides, and low high-density lipoprotein [HDL]). 
This is because numerous studies have shown a high-GI diet is negatively associated with 
HDL-cholesterol and positively associated with triglyceride levels. For example, by using the 
Third National Health and Nutrition Examination Survey, Ford and Liu revealed that 
Americans who consumed high-GI/GL diets had a lower HDL-cholesterol level (Ford et al., 
2001). A systematic review conducted by Clarke et al. showed that when saturated fat was 
replaced by carbohydrates (with no change in caloric intake), subjects had a significant 
decrease in HDL-cholesterol and an increase in triglyceride concentration (Clarke et al., 
1997). In contrast, low-GI diets have beneficial effect on lipid metabolism (Jenkins et al., 
2002; Clapp et al., 2007). For instance, a clinical trial conducted by Ebbeling and colleagues 
showed that obese young adults (n=23) who consumed low-GI diets for 12 months had a 
significant decline in plasma triglyceride (Ebbeling et al., 2005). Also, reanalysis of dietary, 
anthropometric, and biochemical data from the 1986/87 Survey of British Adults (n=2200) 
showed that low GI diets promote the synthesis of HDL-cholesterol in human body (Frost et 
al., 1999). This result is echoed by Liu and colleagues’ study which assessed dietary 
glycemic load in relation with plasma HDL-cholesterol in 185 healthy postmenopausal 
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women by using food frequency questionnaires (Liu et al., 2001). Lastly, some researchers 
believe that low-GI diets may outweigh the conventional low fat diet recommended by the 
American Heart Association in prevention and treatment of CVD (Ford et al., 2001). 
E) Low and high GI/GL foods 
 High GI foods are rapidly digested and absorbed, whereas low GI foods are digested 
and absorbed slowly. High GI foods produce a higher rise in postprandial blood glucose 
levels and a greater overall blood glucose response during the first two hours after 
consumption compared with low GI foods (Foster-Powell et al., 2002). If a food has a GI 
number higher than 70, it is classified as a high GI food; if a food has a GI number lower 
than 55, it is classified as a low GI food. Medium GI foods have GIs in the range of 55-70 
(Brand-Miller et al., 1998). Generally, low GI foods consist of non-starchy vegetables, fruits, 
dairy products, lentils and sugars such as fructose and lactose. Medium GI foods include 
unprocessed grains and mixed dishes. High GI foods are refined grains, potatoes, rice and 
some types of bread (Franz, 2006).  In 2002, Foster-Powell and colleagues brought together 
all the relevant data published between 1981 and 2001 to compose a reliable international 
table of glycemic index and glycemic load values. This table contains approximately 1300 
separate entries, representing more than 750 different types of food (see Table 2) (Foster-
Powell et al., 2002).  
a)  GI of dairy products and the introduction of kefir  
As mentioned above, dairy products have low GI values. Under the category of dairy 
products of the International Table of Glycemic Index and Glycemic Load Values:2002, four 
types of dairy products were tested for GI, they are ice cream, milk, fermented milk, and 
yogurt (Foster-Powell et al., 2002). The GI values (using glucose as the standard) are as 
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follow: ice cream, GI = 61 (regular, mean of five studies); milk, GI = 27 (full-fat, mean of 
five studies); milk, GI = 32 (skim, one study); fermented milk, GI = 11 (3% fat, mean of two 
studies) and yogurt, GI = 14-38 (from lower value for non caloric sweetener to higher value 
for caloric sweetener, nonfat to low fat, range of 14 studies). Our study is interested in the 
type of milk products which are commonly used in most Eastern Europe countries, kefir. Up 
to the present time, no study has measured the GI of kefir. Today, kefir is becoming 
increasingly popular. Some researchers believe that the various health-promoting properties 
of kefir outweigh the benefits of yogurt. With the drastic incline of obesity and diabetes 
world-wide, it is worth to examine if kefir can bring positive effects in helping to combat this 
pandemic disease. 
 Like yogurt, kefir is fermented milk, with a uniform creamy consistency and a 
slightly sour taste. It is originated in the Caucasus Mountains of Russia centuries ago. In the 
past, kefir has been prepared by using cows, goats, and sheep milk. Lately the dairy 
industries have been producing kefir from soy milk. The difference of kefir from the other 
traditional fermented milks (yogurt) is that it is made only from kefir grains (Lopitz-Otsoa et 
al., 2006). Being considered a source of family wealth among the tribes of Caucasus, kefir 
grains were passed from generation to generation in the ancient time. However; today, all 
over the world, traditional kefir can be made by culturing milk with kefir grains (Roberts and 
Yarunin, 2000). Kefir grains are a small cluster of microorganisms that resemble miniature 
cauliflower blossoms. They are a soft, white biological mass, consisting of protein, lipids, 
and a soluble polysaccharide matrix named kefiran that held the mass together (Lopitz-Otsoa 
et al., 2006). Compared with yogurt, kefir has a larger and more diverse range of 
microorganisms in its starter culture, which is composed of yeast and bacteria (Marquina et 
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al., 2002). The kefir beverages used in this study are from Lifeway Kefir, Lifeway Foods, 
Inc., Morton Grove, IL. The drinks contains the following cultures: Lactobacillius lactis,  
Lactobacillus rhamnosus, Streptococcus diacetylactis, Leuconostoc cremoris, Lactobacillus 
plantarum, Lactobacillus casei, Bifidobacterium longum, Bifidobacterium breve, 
Saccharomyces florentinus, and Lactobacillus acidophilus (Lifeway Foods, Inc., 2005a). The 
coexistence of bacteria and yeast in the kefir is proven to be beneficial to health (Lopitz-
Otsoa et al., 2006).  
b) Food factors influencing GI of dairy products 
 The glycemic response is easy to measure; however the mechanism of the response is 
complicated to identify. One of the important facts about GI concept is that it is not a direct 
measure of carbohydrate absorption from the small intestine. Rather, it expresses the 
combined effect of all the physical and chemical properties of a food that can influence the 
rate of carbohydrate absorption in the small intestine (Englyst et al., 2005) for example, type 
of carbohydrate, fat content, protein content, presence of anti-nutrients, ripeness, processing 
and cooking methods (Jenkins et al., 1981). One might wonder why the GI values of dairy 
products are generally low and what are factors that cause the low postprandial glycemic 
response. In term of dairy products, the GI value can be influenced by the type of 
carbohydrate, fat and protein contents. For kefir, fermentation might play a role as well. 
i) Type of carbohydrate 
 Glucose, fructose and galactose are the monosaccharides. By using white bread as a 
standard, Lee and Wolever reported GI value for glucose is 149±16 and GI value for fructose 
is 16±4 (Lee et al., 1998). Maltose, sucrose and lactose are the three major disaccharides. 
Maltose consists of two glucose molecules attached by an alpha-1,4 linkage; therefore its GI 
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value is similar with glucose. Sucrose consists of one glucose molecule and one fructose 
molecule, which are bound by beta-1,4 linkage. The GI value for sucrose is 87±6 by using 
white bread as standard (Lee et al., 1998). Lactose is composed of glucose molecule and 
galactose molecule, which are bound by beta-1,4 linkage. The GI of lactose was reported to 
be 68±8 when using white bread as a standard (Östman et al., 2001). Lactose is the main 
sugar of milk.  
However, in other dairy products such as ice cream, yogurt and kefir, sweeteners are 
used in order to give desirable taste or flavor. In the United States, the main sugar sweeteners 
used are high fructose corn syrup and sucrose (Basciano et al., 2005; Malik et al., 2006; 
Parks et al., 2008). The substantial increase in the amount of dietary fructose consumption 
has drawn tremendous attention. Fructose consumption has controversial effects on lipid and 
glucose metabolism. Numerous studies have examined the effect of oral fructose, either 
given alone or together with a meal on carbohydrate metabolism. In a randomized crossover 
study, 11 healthy subjects were given 75 g of glucose with or without 7.5 g of fructose. The 
glucose AUC was 19% less when glucose was administered with fructose (Moore et al., 
2000).  In another study, when 54 g of fructose was substituted for a similar amount of starch 
in a meal in six individuals with type 2 diabetes and six individual without type 2 diabetes, 
the results showed that fructose has lowering glycemic effect and it can induce less insulin 
secretion compare to starch (Abraha et al., 1998).  Studies have shown sucrose has the same 
effect as fructose which can help to lower glycemic response. When sucrose was 
supplemented to a maltodextrin challenge, Zucker fatty fa/fa rats showed a significant 
decrease of postprandial glycemic response (Wolf et al., 2002). While fructose is believed to 
have lowering glycemic response effect, other researchers have investigated the effect of 
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fructose on lipid metabolism. The most recent dietary sugars on lipid metabolism study 
received great public attention (Parks et al., 2008). In this study, Parks and colleagues 
showed that acute consumption of fructose significantly increased de novo lipogenesis 
compared with glucose consumption when six healthy subjects [aged (mean ± SD) 28 ± 8 y; 
BMI, 24.3 ± 2.8 kg/m²] were tested. Other studies also showed that fructose and sucrose can 
cause hypertriaclyglycerolemia and hypercholesterolemia in animals and humans (Mayers, 
1993; Frayn et al., 1995). Therefore, mono- and disaccharides are not necessarily high in GI 
value as might be expected due to their high bioavailability. In this case, fructose not only 
has a low GI value, but it also could lower the glycemic response of other carbohydrate rich 
food when consumed together.  
ii) Fat and protein 
Fat reduces glycemic response by delaying gastric emptying via the secretion of 
glucose-dependent-insulin-releasing polypeptide (GIP) and glucagons-like polypeptide-1 
(GLP-1) (Owen et al., 2003). In Owen et al.’s study, healthy subjects were recruited to 
consume 50 g available carbohydrate of white bread along with 0, 5, 10, 20, or 40 g fat of 
non-hydrogenated-fat margarine. The results showed that there was no significant 
incremental AUC of blood glucose reduction when white bread was consumed with 5, 10 or 
20 g of fat, but a significant reduction in the incremental AUC of blood glucose (30%) was 
observed when 40 g of fat was taken with the white bread.  On the other hand, some studies 
demonstrated that fat has no effect on glycemic responses in insulin resistance or subjects 
with diabetes. For example, when Gannon et al. fed seven male subjects who had untreated 
noninsulin-dependent diabetes mellitus (NIDDM) with 50 g carbohydrate alone or 50 g 
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carbohydrate with 5, 15, 30, or 50 g fat as a butter, the glucose response was not smaller 
(Gannon et al., 1993). According to Gannon and colleagues, this can be explained by the 
inability of fat to stimulate GLP-1 secretion. 
 It is believed that protein reduces glycemic response by the amino-acid mediated 
effects on insulin secretion (Moghaddam et al., 2006). Nuttall et al. conducted a study to 
determine the effect of protein ingestion on the glucose and insulin response to a 
standardized oral glucose load (Nuttall et al., 1984). Nine male, subjects with untreated 
diabetes were recruited. They were given either 50 g of glucose, 50 g of protein or a 
combination 50 g of glucose with 50 g protein over three consecutive days in a random order. 
The results showed that protein given with glucose would reduce the plasma glucose rise and 
increase insulin secretion in some patients with type II diabetes. A more recent study 
conducted by Moghaddam et al. (2006) agrees with the results of Nuttall et al.. Moghaddam 
et al. also showed that protein reduced postprandial glycemic responses to a greater extent in 
subjects (n=20) with higher waist circumference (r = -0.56, P = 0.011) and higher dietary 
fiber intake (r = -0.60, P = 0.005). They concluded that the effect of protein on glycemic 
response is highly correlated with subjects’ characteristics.  
iii) Fermentation 
The production of organic acids during the fermentation process or added organic  
acid to meals can significantly lower postprandial glucose and insulin responses (Liljeberg & 
Bjorck, 1998). For example, when 20 g white vinegar was added to a starchy meal (n=10 
subjects) (Liljeberg & Bjorck, 1998) or 1 g of vinegar was dressed with lettuce (n=5 
subjects) (Brighenti et al., 1991), it lowered the glucose responses in those healthy subjects 
by more than 30%. Liljeberg and colleagues also demonstrated that consumption of bread 
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products containing lactic acid, either generated during fermentation or added, decreased 
postprandial glycemic and insulinemic responses when tested on 11 healthy, normal BMI and 
aged 26-28 years individuals (Liljeberg et al., 1995; Liljeberg et al., 1996). In terms of 
regular versus fermented milk products, there is controversial evidence to support the glucose 
lowering effect of lactic acid. Sanggaard et al. conducted a study to compare whole milk and 
fermented whole milk, which had the same fat and lactose content (Sanggaard et al., 2004). 
In this study, they did not observe a lower plasma concentration of glucose and insulin after 
the fermented milk, but they were able to show that fermented milk certainly had a slower 
gastric emptying rate than regular milk when tested in eight healthy mean with mean age 
23.9 (s.d. 2.7) years and mean BMI 22.8 (s.d. 1.2) kg/m². Another fermented milk study was 
done by Ostman in Sweden (Ostman et al., 2001). By using regular milk and two commercial 
Scandinavian fermented milk products (yogurt): ropy milk and filmjolk, Ostman et al. did not 
observe significantly lower GI values in 10 healthy, normal weight (BMI= 23.4±2.1 kg/m²) 
subjects for the fermented milk products (GI=15) compare to the regular milk (GI=30). 
According to Ostman et al., the fermented milk products indeed had a lower GI values; 
however because regular milk products already have relatively low GI value, the decrease of 
GI value on filmjolk and ropy milk is not significant. To date, there are two mechanisms 
proposed to explain this metabolic effect, which fermentation process or added organic acids 
to meals can significantly lower postprandial glucose and insulin responses. As mentioned in 
some of the studies above, researchers believed that organic acids delay the rate of gastric 
emptying therefore flatten the postprandial blood glucose and insulin rise (Hunt and Knox, 
1972; Liljeberg et al., 1996). 
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Insulinemic Index 
A) The development of insulinemic index  
 The GI concept is well established. In order to control the plasma glucose levels in 
patients with diabetes, postprandial plasma glucose responses have been the focus of many 
studies. A carbohydrate exchange list is the main tool used by patients with diabetes for 
controlling their blood glucose levels. Recently, a table of GI values was also introduced as a 
supplementary tool to those patients. However, most of the foods tested for GI values have 
not been measured for their concurrent postprandial insulinemic responses. This is because 
insulin secretion is assumed to be proportional to postprandial blood glucose responses 
(Brouns et al., 2005). Numerous research studies have shown that a carbohydrate is not the 
only stimulus for insulin secretion. A number of insulinotropic factors that mediate 
postprandial insulin secretion include fructose, certain amino acids, fatty acids, and 
gastrointestinal hormones such as gastric inhibitory peptide, glucagon, and cholecystokinin 
(Nuttall et al., 1991; Morgan, 1992). Due to these insulinotropic factors, some foods might 
cause postprandial hyperinsulinemia. Research has shown hyperinsulinemia is one of the risk 
factors for the development of many diseases, such as obesity, arteriosclerosis, diabetes, 
cancer and dyslipidemia (DeFronzo et al., 1991; Brouns et al., 2005). According to Del Prato 
et al., chronic, physiologic hyperinsulinaemia, whether created by exogenous insulin infusion 
or by stimulation of endogenous insulin secretion, can lead to the development of insulin 
resistance (Del Prato et al., 1994). Insulin resistance is a key factor that causes metabolic 
syndrome. As a result, a critic of GI, Hollenbeck, proposed that any estimate of metabolic 
response should include measurements of both plasma glucose and insulin (Hollenbeck et al., 
1986). While the measurement of postprandial blood glucose responses is important for 
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patients with diabetes in controlling their blood level, the measurement of postprandial 
insulinemic responses is equally important (Holt et al., 1997).  
  Insulinemic index (II) is calculated in the same fashion as the GI. The formula for II 
is as follow. 
 
The methodology of II is consistent with the measurement of GI. However, instead of using 
50 g of available carbohydrate as the portion of the foods, there are some studies conducted 
by Holt et al. that used 1000 kJ (240 kcal) portion size (Holt et al., 1996; Holt et al., 1997). 
This is because 1000 kJ is a more realistic meal in terms of what people habitually eat.  
B) Discrepancy between GI and II of milk 
In general, pure carbohydrate, sugars and starchy foods have a high correlation 
between glycemic and insulinemic responses (Lee et al., 1998). Combine data from other 
studies, Björck et al. examined 43 starchy foods and concluded that the postprandial insulin 
level is higher after the consumption of high-GI, starchy foods than low-GI, starchy foods 
(Björck et al., 2000). On the other hand, studies have shown that non-starchy foods can 
produce higher insulin responses than expected from their GI (Östman et al., 2001; Holt et 
al., 1997).  
Incremental blood insulin area 
of test food 
 
Incremental blood insulin area of 
reference food 
 
× 100 II  =  
32 
 The GI of milk is in the low range; however, when milk was tested for its 
postprandial insulin responses, it gives high AUC. Therefore, milk is one of the non-starchy 
foods which have an inconsistency of GI and II (Ostman et al., 2001; Liljeberg et al., 2001). 
In Ostman et al.’s single study, they tested one type of regular milk and two types of 
fermented milk: ropy milk and filmjolk by using white bread as the standard. The GI values 
for all three milk products were very low, ranging from 12 to 30 which are in accordance 
with the literature data; however the II values were very high relative to their GIs (reported to 
be similar with the reference meal’s value). In this study, they also tested the GI and II for 
lactose solution. The results showed that GI of lactose correlated very well with its II value, 
suggesting that some milk components can stimulate insulin secretion, but not lactose 
content. Prior to the study of Ostman et al., inconsistency between GI and II of milk products 
have been noted in Gannon and colleagues’ study when 50 g carbohydrate of skim milk were 
given to seven subjects with type 2 diabetes age 64±3 years and with BMI of 32.2±1.7 kg/m²  
(Gannon et al., 1986). However, this discrepancy has not been acknowledged until the study 
of Ostman et al. in year 2001. When this intriguing result was observed, Lijeberg and Bjorck 
decided to conduct a study to confirm the findings of Ostman et al. by supplementing milk to 
a high-GI white bread and a low-GI spaghetti meal to 10 healthy volunteers, seven men and 
three women, aged 22-30 years, with normal BMI (Liljeberg and Bjorck, 2001). The 
insulinotrophic effect of milk in this study is consistent with Ostman et al. which 
demonstrated that both bread and spaghetti had higher insulin responses when milk was 
given compared with water. The insulinotrophic effect of milk products has not been 
understood. There are many potential unexplored mechanisms for the discrepancy of GI and 
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II. However, two non-carbohydrate components, protein and fat in the milk are believed the 
most potent insulin secretagogues.  
a) Factors causing discrepancy 
i) Insulinogenic effect of protein 
Different food proteins differ in their effect on glucose metabolism in humans (Holt 
et al.,1997; Nuttall et al., 1991; Floyd et al., 1966). In term of milk products, according to 
Nilsson et al., it is the whey fraction of the milk protein which possesses most of the 
insulinotropic properties in milk products. This is because about 80% of milk proteins are 
casein and 20% are whey. Casein clots easily to form gel like structure under low pH 
condition, but not whey. Therefore, when milk gets into the stomach (low pH environment), 
the only soluble component of milk is whey protein (Nilsson et al., 2004). Whey is then 
rapidly digested and absorbed to release amino acids into the circulation (Boirie et al., 1997). 
Studies have shown that certain amino acids are potent insulin secretagogue especially the 
branched-chain amino acids (leucine, isoleucine and valine) (Schmid et al., 1989). Nilsson 
and colleagues conducted an experiment mainly to compare an amino acids drink mixture 
which contains all five amino acids: leucine, isoleucine, valine, lysine, and threonine with 
whey protein drink (Nilsson et al., 2007). In this study, 12 healthy subjects (aged 20- 30; 
BMI 19.5- 25.7 kg/m²) were given drinks consisting of pure glucose or glucose supplemented 
with free amino acids or whey proteins. Their results showed that the glycemic and 
insulinemic responses of the amino acid drink mixture mimicked those seen after whey 
ingestion. All in all, one can say that the whey fraction of milk products which consists of 
leucine, isoleucine, valine, lysine and threonine are potent stimulators of insulin secretion.   
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 Another possible pathway to explain the insulinotropic effect of milk products 
proposed by Nilsson and colleagues is via the activation of the incretion system. After a meal 
digestion, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 
(GLP-1) are released. These hormones are important to stimulate the secretion of insulin 
(Drucker, 2007). Some studies showed that only fat and carbohydrates are the stimulants of 
GLP-1 and GIP, but less with proteins (Elliott et al., 1993; Hermann et al., 1995; Cataland et 
al., 1974; Pederson et al., 1975), while other studies have indicated that amino acids do 
stimulate GLP-1 and GIP release in response to a meal in both healthy subjects and subjects 
with type 2 diabetes (Simpson et al., 1985; Fieseler et al., 1995; Carr et al., 2008). In Nilsson 
and colleagues’ study, when whey meal was served to 12 healthy subjects, the AUCs for 
plasma GIP concentration is significantly higher than the 25 g carbohydrate of white-wheat-
bread as reference meal (Nilsson et al., 2004). As a result, this higher GIP response after 
whey meal may be one of the factors that stimulate insulin secretion. 
ii)  Insulinogenic effect of fat 
Another non-carbohydrate component in milk that is believed to have  
insulinotropic property is the fat content (Ostman et al., 2001). It is known that fat ingestion 
can stimulate the secretion of GLP-1 and GIP (Herrmann et al., 1995; Deacon et al., 2005). 
Collier and O’Dea conducted a study to examine the effect of coingestion of fat on the 
glucose, insulin, and GIP responses to carbohydrate and protein (Collier and O’Deal, 1983). 
When eight lean, weight-stable subjects were fed 50 g of carbohydrates (potato) with 50 g of 
fat (butter), the postprandial glycemic response was reduced but the postprandial insulin 
response remained as high as the reference meal (50 g of carbohydrate). The results also 
showed that the addition of fat to carbohydrate meal gave rise to a significant higher plasma 
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GIP response. As a result, the authors concluded that fat can stimulate the secretion of insulin 
via the incretin hormone, GIP. Recently, Carr and colleagues conducted a research study that 
revealed a new perspective towards incretin and islet hormonal responses to fat ingestion in 
healthy men (Carr et al., 2008). In this study, after fat ingestion, insulin increased 
immediately and with a peak at 30 to 60 minute time point; however, the circulating incretin 
levels only began to rise after 30-60 minutes. Therefore, Carr and colleagues proposed that 
besides activating insulin secretion through a direct action on beta cells, incretins might also 
stimulate insulin secretion through a neural effect via vagal efferent fibres innervating the 
pancreas when fat was ingested. Based on the finding of Collier and O’Dea, Hoyt and 
colleagues decided to investigate if a fat component is the reason causing the dissociation of 
GI and II in milk products (Hoyt et al., 2005). In this study, they fed nine healthy subjects 
with both skim milk and whole milk at two separate occasions. However, the results showed 
that no significant differences existed between GI and II for skim and whole milks. The GI 
and II for whole milk is 41 and 148 respectively, whereas the GI and II for skim milk is 37 
and 140 respectively. Therefore, their results again confirmed with the previous studies that 
milk is a potent insulin secretagogue, but they ruled out the possible insulinotropic effect of 
fat content in milk.  
b) Milk products and health concern 
 Hyperinsulinaemia could lead to the development of many other diseases, and milk 
products have an insulinotropic effect after ingestion. Therefore, should we be drinking milk 
or consuming dairy products? Since the researchers have not been able to elucidate the 
mechanism that causes the insulinotropic effect of milk products, should caution be taken 
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when dietary recommendation of dairy consumption is given to healthy individual or patients 
with diabetes? 
Thus far, there is lack of consensus regarding the effects of milk consumption on the 
risk of diabetes, obesity, insulin resistance or metabolic syndrome (Pfeuffer and 
Schrezenmeir, 2006). Few studies have demonstrated an association between higher diary 
consumption and lower risk of some metabolic diseases. For example, after 12 years of 
observation, the 41,254 male participants with no history of diabetes, cardiovascular disease 
and cancer, at baseline in the Health Professionals Follow-up Study, showed an inverse 
relationship of dairy intake with risk of type 2 diabetes. In other words, after adjusting for 
potential confounders, each serving-per-day increase in total dairy intake was associated with 
a 9% lower risk for type 2 diabetes (multivariate relative risk, 0.91; 95% CI, 0.85-0.97) (Choi 
et al., 2005). Coronary Artery Risk Development in Young Adults (CARDIA)  demonstrated 
that the 10-year incidence of  insulin resistance syndrome was lower by more than two thirds 
among overweight individuals in the highest category of dairy consumption (≥5/d) compared 
with those in the lowest category (<1.5/d). Besides insulin resistance, dairy consumption was 
inversely associated with all other components of the metabolic syndrome as well (Pereira et 
al., 2002). When the observational study was conducted in the low-income-country 
Argentina, the same results were shown. In this study, 365 school children age 10±2.3 years 
from two poor suburbs of Buenos Aires were recruited to determine the association between 
milk consumption, lifestyle, components of the metabolic syndrome, and insulin resistance. 
Multiple regression analysis was performed. When insulin resistance was used as the 
dependent variable, the results showed that there was a significant and positive association 
between insulin resistance and triglyceridemia (β = 0.007) as well as insulin resistance and 
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waist circumference (β = 0.024); however, there was a negative association between insulin 
resistance and milk consumption (β = -0.135). As a result, they concluded that increased milk 
consumption was associated with greater insulin sensitivity, hence decreased risk of type 2 
diabetes (Hirchler et al., 2008).  
On the contrary, few other recent studies showed negative effect of dairy 
consumption with some of the metabolic diseases. For example, 1,124 participants of the 
Hoorn Study demonstrated that higher dairy consumption did not protect against weight gain 
and development of metabolic disturbances in a Dutch elderly population (Snijder et al., 
2008). In the British Women’s Heart and Health Study, 4024 British women ages 60-79 were 
randomly recruited from primary care centers. Women who never drank milk had lower 
homeostasis model assessment insulin resistance (HOMA) scores, triglyceride concentrations 
and body mass index, and higher high-density lipoprotein (HDL)-cholesterol concentrations, 
than those who drank milk. Therefore, this study implied individuals who do not drink milk 
may be protected against insulin resistance and the metabolic syndrome (Lawlor et al., 2005). 
By and large, the differences in study population, study design, and methodology can 
contribute to the conflicting results of the beneficial effect of dairy consumption. Before 
more conclusive results can be proven regarding the negative effects of dairy consumption on 
metabolic syndrome and insulin resistance, the public should not be advised to avoid dairy 
consumption. This is because various components of dairy have been suggested to bring 
other benefits, for example dairy is a good source of calcium and potassium. These two 
elements are important for the elderly to prevent the development of osteoporosis and for the 
children to grow. Dairy proteins and peptides enhance the bioavailability of other minerals 
and trace elements like magnesium, manganese, zinc, selenium and iron (Vegarud et al., 
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2000). Besides that, studies have shown dairy intake may promote a healthy lifestyle and 
better eating habits. Currently in United States, reduction of milk intake among young 
children and adolescents is a public health concern (Kvaavik et al., 2005). There are 
numerous epidemiological studies showed that liquid dairy beverages may replace sweetened 
soda drinks especially in children and adolescents (Johnson et al., 2000; Nielsen et al., 2001; 
Kranz et al., 2005).  
Satiety index 
A) Glucostatic theory and postabsorptive metabolic events of low and high-GI diets 
Satiation is defined as the sensation of fullness that develops during the progress of a 
meal and contributes to meal termination, whereas satiety is defined as the sensation of 
fullness between one meal and the next (Roberts, 2000). Satiety may determine the length of 
the intermeal interval and the amount of food consumed during the next eating episode. 
There are many factors that influence the onset and termination of eating. They can be 
categorized as external or internal factors. External environment factors include sensory 
hedonics, tension reduction, social pressure and boredom. Internal factors include humoral 
and neural signals from the gastrointestinal system and from adipose tissue (de Graaf et al., 
2004). One of the external humoral signals that causes the onset and termination of eating is 
glucose. In 1953, Jean Mayer first proposed the glucostatic theory for short-term appetite 
regulation. Based on this theory, a decrease in glucose utilization due to its low concentration 
indicated the onset of meal initiation, whereas an increase in glucose utilization due to its 
high concentration indicated the termination of meal intake. However, later research studies 
discovered it is the transient decline in blood glucose rather than the absolute blood glucose 
concentration that gives a signal to glucostatic receptors in the central nervous system that 
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fuel is low and the body needs to be replenished (Louis-Sylvestre et al., 1980; Smith et al., 
1993; Campfield et al., 1990; Lavin et al., 1996).  
Currently, many researchers promote the use of low GI diets to combat the pandemic 
health issues, obesity and diabetes. Varied postprandial metabolic events elicited by high GI 
and low GI diets are hypothesized to have potential effects on satiety. Consumption of high 
GI meals causes a sharp increase in plasma glucose concentration during the early (first hour) 
postprandial period. The rapid increase of blood glucose stimulates the release of insulin 
from the pancreatic-beta cells and suppresses the release of glucagon from the alpha cells. 
According to glucostatic theory, the rise of glucose concentration after the meal will signal 
satiety and terminate food intake. However, this rapid increase of blood glucose 
concentration due to the ingestion of rapidly digestible, high GI carbohydrates will only 
suppress hunger and appetite in the short-term (≤ 1 h). In  Anderson and colleagues’ study 
(2002), fourteen healthy, nonsmoking men, ages 18-35 years with a body mass index of 20-
25 kg/m², were recruited to determine the effect of the four carbohydrate sources on 
subjective measures of satiety and short-term food intake. The results showed that food 
intake and subjective appetite were inversely associated with blood glucose response in 60 
minutes after consumption of the carbohydrates.  Two to four hours after the consumption of 
high GI meal, hyperinsulinaemia persists and results in a rapid fall of blood glucose 
concentration. This fall of blood glucose concentration often goes below basal concentration 
which leads to a hypoglycemic stage. Hypoglycemia is caused by high GI diet that 
accelerates hunger 2-4 hours and beyond (Bornet et al., 2007). On the other hand, low GI 
diets produce lower and longer postprandial blood glucose rise especially in the early stage. 
This would gradually release insulin into the blood stream to help with glucose uptake and 
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the phenomena of hypoglycemia is prevented. According to Ludwig, slower absorption 
enables prolonged stimulation of nutrient receptors in the gastrointestinal tract and thus 
causes a prolonged satiety signal to the brain (Ludwig, 2002). As a result, it is hypothesized 
that low GI diets can attenuate hunger and therefore lead to less food intake.  
B) Studies examining the relationships between GI and satiety 
 Many studies have been conducted to examine the relationship between glycemic 
index and satiety. However, the results of the studies are inconsistent. Some found no effect 
of GI on satiety and food intake, while others found a significant suppression of hunger and 
appetite after consumption of the low GI diets. A recent article written by Bornet et al., 
reviewed 19 human studies, testing carbohydrate foods or mixed meals on the impart of 
satiety (Bornet et al., 2007). The following part of the thesis will discuss some of these 
studies. There are many confounding variables that can influence the glycemic responses on 
satiety; therefore, in this review article, Bornet et al. carefully eliminated those variables. For 
example, they selected studies that have the same energy content and same carbohydrate, 
protein and fat contents of the tested meals. This is because macronutrients possess their own 
satiating powers. Protein is considered to be more satiating than carbohydrates and 
carbohydrates are more satiating than fat (Rolls et al., 1988; Stubbs, 1995). Even though fiber 
could influence satiety, the effect of fiber is not controlled by most of the mixed meals 
human studies; therefore, Bornet et al. were not able to take fiber into account for selection 
criteria. In this review article, when subjective method of assessment was used in the studies, 
Bornet et al. showed that 12 of 18 studies supported an inverse relationship between GI diets 
and satiety, which means low glycemic index food, produces high satiety. Moreover, when 
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an objective method of assessment was used (ad libitum food intake) in the studies, four of 
seven showed similar results.  
 Arumugam and colleagues studied the effects of variations in postprandial glycemia 
on subjective satiety in overweight and obese women (Arumugam et al., 2008). Fourteen 
nonsmoking, overweight and obese women between the ages of 35 and 60 years were 
recruited to participate in this within-subjects’ designed study. In order to model the 
postprandial effects of high GI meal and low GI meal, the investigators altered the ingestion 
rate of a glucose beverage. At one visit, the subjects were required to consume a large 
glucose drink (60 g glucose) with breakfast to mimic the high GI meals; at the other visit, the 
subjects were served the same amount of glucose but it was divided into eight equal portions, 
with one portion consumed with breakfast and the seven other portions consumed at 20-
minute intervals after the breakfast to mimic the low GI meals. The results showed that 
subjects experienced higher fullness with the slower ingestion of glucose beverage (low GI 
meal) compared with the rapid ingestion of glucose beverage (high GI meal) four hours after 
the breakfast meals.  
 Ball et al. investigated the effects of low-GI whole-food meals (LWM), high-GI 
meal-replacement (HMR) and low-GI meal-replacement (LMR) on metabolic, hormonal and 
satiety responses in 16 overweight adolescents (Ball et al., 2003). It was a randomized, 
crossover study with three separate 24-hour admissions visits. The results showed that even 
though no differences were observed in subjective hunger ratings and voluntary energy 
intake, meals were requested earlier after HMR treatment compared to the LMR treatment 
(3.1 versus 3.9 hours, respectively). Therefore, the authors concluded that low-GI diets can 
prolong satiety, which may lead to reduced caloric intake and long-term weight control.   
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 Due to chemical structure differences, amylose and amylopectin have different effects 
on postprandial glucose and insulin concentrations. Amylose produces a significantly lower 
postprandial glycemia and insulinemia response compared with amylopectin. Taking 
advantage of these differences, van Amelsvoort and Weststrate decided to conduct a study 
examining the postprandial effects of changing the amylose-to-amylopectin ratio (Am:Ap) in 
the starch fraction of a meal (van Amelsvoort and Weststrate, 1992). Twenty-two normal 
weight and healthy male volunteers were recruited to participate in this study. They were 
required to consume hot mixed lunches in which Am:Ap was either 0:100 or 45:55. The 
results demonstrated that the low-GI meal (high Am:Ap) elicited higher satiety value 
compared with the high-GI meal (low Am:Ap).     
 In terms of long-term intervention, Henry and colleagues conducted a study to 
examine the effects of low- and high-glycemic index breakfasts on food intake in children 8-
11 years old (Henry et al., 2007). It was a randomized cross-over design study where children 
were assigned to one of two groups. On two non-consecutive days per week, for 10 weeks, 
each group was given low-GI and high-GI breakfasts. After breakfast, subjects would stay 
for an ad libitum buffet lunch. The foods eaten during the lunch were recorded. In order to 
obtain daily energy and macronutrient intakes, the subjects were required to record 3-day 
food dairies and they were interviewed for 24 hour food recall. The results showed that even 
thought the mean difference of 75 kJ was not statistically significant (P=0.406), there was a 
tendency towards a reduced energy intake at lunch following the low-GI breakfast compared 
with the high-GI breakfast. Besides that, 3-day food dairies showed that there was a tendency 
toward a reduced energy intake during the low-GI study period compared with high-GI study 
period. 
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 Barkeling and colleagues studied the effects of carbohydrates in the form of pasta and 
bread on food intake and satiety (Barkeling et al., 1995). By using similar raw material, 
carbohydrates in the form of pasta produced a low and stable glucose and insulin response 
(low-GI meal), while carbohydrates in the form of bread produced a high glucose and insulin 
response (high-GI meal). Sixteen normal weights, elderly men were recruited in this study. 
They were served a pasta breakfast and a bread breakfast in a randomized cross over design. 
Their subjective rating of hunger was measured by using 100 mm Visual Analogue Scales 
from before breakfast to after lunch. Three hours after their breakfast, they were served an ad 
libitum lunch meal. Their food intakes during the lunch meal were measured by VIKTOR a 
universal eating monitor. The results of the study demonstrated that even though two types of 
breakfast meals produced significant difference of insulin and glucose responses, there was 
no difference in satiety response. Subjects in low-GI breakfast group consumed as much as 
subjects in high-GI breakfast group during their lunch meal.  
C) The development of satiety index 
There are two ways of measuring appetite in humans. First, the degree of hunger can 
be estimated via subjective ratings. Humans have the ability to rate the strength of their 
conscious drive and motivation to eat (de Graaf et al., 2004). To date, there are two kinds of 
subjective ratings used by researchers: seven point rating scales and 100 mm visual analogue 
scales (VAS). Studies have shown that subjective ratings are reproducible, sensitive to 
exposures of food components, and predictive of food intake (Holt et al., 1995; Flint et al., 
2000; Stubbs et al., 2000). The second way to measure one’s appetite is by the actual amount 
of food eaten after a preload test meal. Foods eaten ad libitum after the test meals are 
recorded. However, the amount of food eaten should be observed instead of deriving 
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information from dietary food records or recalls. This is because the food eaten by subjects 
obtained from dietary records or recalls is not precise and valid (de Vries et al., 1994).  
In 1995, Holt and colleagues saw the need for developing a system to produce a table 
showing the energy-satiety ratio of a list of common foods; thus, introducing the concept of 
satiety index (SI) to the nutritional field (Holt et al., 1995). Holt et al. believed that energy-
equivalent loads of the different nutrients can have different effects of satiety, thermogenesis, 
carbohydrate and fat storage. Even though a number of studies have shown that different 
types of nutrients and foods satisfy hunger to varying extents, we still have a limited 
understanding of the complex interacting mechanisms of satiation (Holt et al., 1995). In the 
future an international table of satiety index values of foods might be established by using 
this concept. SI is calculated in the same fashion as the GI; however instead of using 50 g of 
available carbohydrate as the portion, it uses isoenergetic portions of foods. Rating scale (see 
Figure 1) instead of the 100 mm VAS was used by Holt and colleagues. The formula for SI is 
as follows. The denominator also differs slightly from that used in GI. In SI, the group 
average AUC for the reference food is used instead of the individual’s AUC. This is because 
some subjects might experience very little fullness for the reference food and express zero 
results.  
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Figure 1. The visual analog scale used in satiety index testing. 
 
 
One of the purposes of our study is to measure the satiety index of kefir drinks. As 
mentioned above, the concept of satiety index was first introduced by Holt and Brand-
Miller’s lab in order to produce a table showing the energy-satiety ratio of a list of foods 
(Holt et al., 1995). Therefore, we are interested in knowing the SI score (%) of kefir 
compared with the list of 38 foods tested by Holt et al. on an isoenergetic basis. Moreover, in 
a later publication, Holt et al. used these SI score (%) of 38 foods to determine whether the 
postprandial increments in subjective satiety, plasma glucose and insulin responses were 
interrelated (Holt et al., 1996). This is because Holt and colleagues believed that postprandial 
increments in plasma glucose and/or insulin are likely to be among the physiological 
mechanisms responsible for the satiating effect of foods. Therefore, our study is also 
designed to determine the interrelationships among postprandial satiety, glucose and insulin 
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responses. In Holt et al.’s study, the results showed that there were no significant correlations 
between the glucose and insulin AUC values and satiety AUC values (both r = 0.06). 
Similarly, there were no significant correlations between the glycemic and insulin index 
scores and satiety index scores (r = 0.11 and r = -0.08).  
 
Literature cited 
 
 (2008a). World Health Organization. Obesity and overweight. [cited 2008 July 23]. 
Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. 
 
(2008b). International Diabetes Federation. Diabetes atlas. Brussels: International Diabetes 
Federation. [cited 2008 July 23]. Available from: http://www.idf.org. 
 
(2008c). American Diabetes Association. Diabetes prevention. How to prevent or delay 
diabetes: Making healthy food choices. [cited 2008 July 23]. Available from: 
http://www.diabetes.org/diabetes-prevention/nutrition/healthyfoodchoices.jsp 
 
Abraha A, Humphreys SM, Clark ML, Matthews DR, Frayn KN. (1998) Acute effect of 
fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br J Nutr 80(2), 169-
175. 
 
Anderson GH, Catherine NL, Woodend DM, Wolever TM. (2002) Inverse association 
between the effect of carbohydrates on blood glucose and subsequent short-term food intake 
in young men. Am J Clin Nutr. 76(5), 1023-1030. 
 
Arumugam V, Lee JS, Nowak JK, Pohle RJ, Nyrop JE, Leddy JJ, Pelkman CL. (2008) A 
high-glycemic meal pattern elicited increased subjective appetite sensations in overweight 
and obese women. Appetite. 50(2-3), 215-222. 
 
Astrup A. (1993) Dietary composition, substrate balances and body fat in subjects with a 
predisposition to obesity. Int J Obes 17 (suppl 3), S32-S36. 
 
Astrup A, Flatt JO. (1994) Metabolic determinants of body weight regulation. In: Bouchard 
C, bray G, eds. Regulation of Body Weight: Biological and Behavioural Mechanisms. Life 
Science Research Report 57. Chichester. UK: John Wiley & Sons: 193-210. 
 
Astrup A, Raben A. (1995) Carbohydrate and obesity. Int J Obes 19 (suppl 5), S27-S37. 
 
Astrup A, Gøtzsche PC, van de Werken K, Ranneries C, Toubro S, Raben A, Buemann B. 
(1999) Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr. 
69(6), 1117-22.  
47 
 
Attvall S, Fowolin J, Lager L, Von Schenck H, Smith U. (1993) Smoking induces insulin 
resistance- a potential link with the insulin resistance syndrome. Journal of Internal Medicine 
233, 327-332.  
 
Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Mehta R, Franco A, Olaiz G et al. (2005) 
The metabolic syndrome: a concept hard to define. Arch Med Res 36, 223-231. 
 
Ball SD, Keller KR, Moyer-Mileur LJ, Ding YW, Donaldson D, Jackson WD. (2003) 
Prolongation of satiety after low versus moderately high glycemic index meals in obese 
adolescents. Pediatrics. 111(3), 488-494. 
 
Bantle JP, Raatz SK, Thomas W, Georgopoulos A. (2000) Effects of dietary fructose on 
plasma lipids in healthy subjects. Am J Clin Nutr 72(5), 1128-1134. 
 
Barkeling B, Granfelt Y, Bjorck I (1995) Effects of carbohydrates in the form of pasta and 
bread on food intake and satiety in man. Nutrition Research 15, 467-476. 
 
Basciano H, Federico L, Adeli K. (2005) Fructose, insulin resistance, and metabolic 
dyslipidemia. Nutr Metab (Lond) 2(1), 5. 
 
Bornet FR, Jardy-Gennetier AE, Jacquet N, Stowell J. (2007) Glycaemic response to foods: 
impact on satiety and long-term weight regulation. Appetite. 49(3), 535-553. 
 
Brand-Miller J, Foster-Powell K, Colagiuri S & Leeds A. (1998) The GI factor-The glucose 
revolution. Holder Headline Austrialia Pty Ltd. 
 
Brand-Miller J, Holt SH, Pawlak DB, McMillan J. (2002) Glycemic index and obesity. Am J 
Clin Nutr 76, 281S-5S.  
 
Brand-Miller J. (2003a) Glycemic load and chronic disease. Nutr Rev 61, S49-55. 
 
Brand-Miller J, Hayne S, Petocz P, Colagiuri S. (2003b) Low-glycemic index diets in the 
management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 
26(8), 2261-2267. 
 
Brand-Miller J, Dickinson S, Barclay A, Celermajer D. (2007) The glycemic index and 
cardiovascular disease risk. Curr Atheroscler Rep 9(6), 479-85.  
 
Brand-Miller J, McMillan-Price J, Steinbeck K, Caterson I. (2008) Carbohydrates--the good, 
the bad and the whole grain. Asia Pac J Clin Nutr 17 ( suppl 1), 16-9. 
 
Brighenti F, Castellani G, Benini L, Casiraghi MC, Leopardi E, Crovetti R, Testolin G. 
(1995) Effect of neutralized and native vinegar on blood glucose and acetate responses to a 
mixed meal in healthy subjects. Eur J Clin Nutr 49(4), 242-247. 
48 
 
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TMS. (2005) 
Glycaemic index methodology. Nutrition Research Reviews 18, 145-171. 
 
Buyken AE, Toeller M, Heitkamp G, Karamanos B, Rottiers R, Muggeo M, Fuller JH; 
EURODIAB IDDM Complications Study Group. (2001) Glycemic index in the diet of 
European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum 
lipids. Am J Clin Nutr. 73(3), 574-581. 
 
Campfield LA, Smith FJ. (1990) Transient declines in blood glucose signal meal initiation. 
Int J Obes 14 (suppl 3), 15-31.  
 
Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahren B. (2008) 
Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J 
Physiol Endocrinol Metab. [Epub ahead of print] 
 
Caso EK. (1950) Calculation of Diabetic Diets. Report of the Committee on Diabetic Diet 
Calculations, American Dietetic Association. Prepared Cooperatively with the Committee on 
Education, American Diabetes Association and Diabetes Branch, U.S. Public Health Service. 
Journal of the American Dietetic Association 26, 575–582. 
 
Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L, 
Taboga C. (1998) Antioxidant defences are reduced during the oral glucose tolerance test in 
normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest 28(4), 329-33. 
 
Ceriello A, Bortolotti N, Motz E, Pieri C, Marra M, Tonutti L, Lizzio S, Feletto F, Catone B, 
Taboga C. (1999) Meal-induced oxidative stress and low-density lipoprotein oxidation in 
diabetes: the possible role of hyperglycemia. Metabolism 48(12), 1503-1508. 
 
Ceriello A. (2000) The post-prandial state and cardiovascular disease: relevance to diabetes 
mellitus. Diabetes Metab Res Rev 16(2), 125-32. Choi HK, Willett WC, Stampfer MJ, Rimm 
E, Hu FB. (2005) Dairy consumption and risk of type 2 diabetes mellitus in men: a 
prospective study. Arch Intern Med. 165(9), 997-1003.  
 
Clarke R, Frost C, Collins R, Appleby P, Peto R. (1997) Dietary lipids and blood cholesterol: 
quantitative meta-analysis of metabolic ward studies. BMJ 314(7074), 112-117.  
 
Clapp J, Lopez B. (2007) Low-versus high-glycemic index diets in women: effects on caloric 
requirement, substrate utilization and insulin sensitivity. Metab Syndr Relat Disord  5(3), 
231-242. 
 
Collier G, O'Dea K. (1983) The effect of coingestion of fat on the glucose, insulin, and 
gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr. 37(6), 
941-944. 
 
49 
Crapo PA, Reaven GM, Olevsky J. (1976) Plasma glucose and insulin responses to orally 
administered simple and complex carbohydrates. Diabetes 25, 741-747.  
 
Crapo PA, Reaven GM, Olevsky J. (1977) Post-prandial plasma-glucose and insulin 
responses to different complex carbohydrates. Diabetes 26, 1178-1183.  
 
Crapo PA, Kolterman OG, Waldeck N, Reaven GM, Olevsky J. (1980) Postprandial 
hormonal responses to different types of complex carbohydrates in individuals with impaired 
glucose tolerance. Am J Clin Nutr 33, 1723-1728.  
 
Deacon CF. (2005) What do we know about the secretion and degradation of incretin 
hormones? Regul Pept. 128(2), 117-124. 
 
DeFronzo RA, Barzilai N, Simonson DC. (1991) Mechanism of metformin action in obese 
and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 73(6), 1294-301. 
 
de Graaf C, Blom WA, Smeets PA, Stafleu A, Hendriks HF. (2004) Biomarkers of satiation 
and satiety. Am J Clin Nutr. 79(6), 946-961. 
 
de Vegt F, Dekker JM, Ruhé HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. (1999) 
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn 
population: the Hoorn Study. Diabetologia 42(8), 926-31. 
 
de Vries JH, Zock PL, Mensink RP, Katan MB. (1994) Underestimation of energy intake by 
3-d records compared with energy intake to maintain body weight in 269 nonobese adults. 
Am J Clin Nutr 60(6), 855-860. 
 
Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. (1994) Effect 
of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and 
insulin sensitivity in man. Diabetologia 37, 1025-1035. 
 
Doucet E, Imbeault P, St-Pierre S, Alméras N, Mauriège P, Richard D, Tremblay A. (2000) 
Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up. Int J 
Obes Relat Metab Disord. 24(7), 906-14. 
 
Drucker DJ. (2007) The role of gut hormones in glucose homeostasis. J Clin Invest. 117(1), 
24-32.  
 
Ebbeling CB, Leidig MM, Sinclair KB, Seger-Shippee LG, Feldman HA, Ludwig DS. (2005) 
Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in 
obese young adults. Am J Clin Nutr 81(5), 976-82.  
 
Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. (1993) Glucagon-like 
peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in 
50 
response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J 
Endocrinol. 138(1), 159-166. 
 
Englyst KN, Englyst HN. (2005) Carbohydrate bioavailability. Br J Nutr 94(1), 1-11. 
 
Facchini FS, Hua N, Abbasi F, Reaven GM. (2001) Insulin resistance as a predictor of age-
related diseases. J Clin Endocrinol Metab 86(8), 3574-8. 
 
Fieseler P, Bridenbaugh S, Nustede R, Martell J, Orskov C, Holst JJ, Nauck MA. (1995) 
Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but 
not by CCK-8. Am J Physiol. 268(5 Pt 1), E949-55. 
 
Filozof CM, Murúa C, Sanchez MP, Brailovsky C, Perman M, Gonzalez CD, Ravussin E. 
(2000) Low plasma leptin concentration and low rates of fat oxidation in weight-stable post-
obese subjects. Obes Res. 8(3), 205-10. 
 
Flint A, Raben A, Blundell JE, Astrup A. (2000) Reproducibility, power and validity of 
visual analogue scales in assessment of appetite sensations in single test meal studies. Int J 
Obes Relat Metab Disord. 24(1), 38-48. 
 
Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. (1966) Insulin secretion in response to 
protein ingestion. J Clin Invest. 45(9), 1479-1486. 
 
Food and Agriculture Organization (1998) Carbohydrates in Human Nutrition: Report of a 
Joint FAO/WHO Expert Consultation, Rome, 14-18 April 1997. FAO Food and Nutrition 
Paper no. 66. Rome: FAO. 
 
Ford ES, Liu S. Glycemic index and serum high-density lipoprotein cholesterol concentration 
among US adults. Arch Intern Med 161, 572-576. 
 
Foster-Powell K, Holt SHA, Brand-Miller JC. (2002) International table of glycaemic index 
and glycaemic load values. American Journal of Clinical Nutrition 76, 5-56. 
 
Franz MJ. (2006) The argument against glycaemic index: what are the other options? Nestle 
Nutr Workshop Ser Clin Perform Programme 11, 57-72. 
 
Frayn KN, Kingman SM. (1995) Dietary sugars and lipid metabolism in humans. Am J Clin 
Nutr 62(1 Suppl), 250S-263S. 
 
Frid AH, Nilsson M, Holst JJ, Björck IM. (2005) Effect of whey on blood glucose and 
insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J 
Clin Nutr. 82(1), 69-75. 
 
Friedman MI. (1995) Control of energy intake by energy metabolism. Am J Clin Nutr 62(5 
Suppl), 1096D-1100S. 
51 
 
Frati AC, Iniestra F, Ariza CR. (1996) Acute effect of cigarette smoking on glucose tolerance 
and other cardiovascular risk factors. Diabetes Care 19, 112-118. 
 
Frost G, Leeds AA, Doré CJ, Madeiros S, Brading S, Dornhorst A. (1999) Glycaemic index 
as a determinant of serum HDL-cholesterol concentration. Lancet 353(9158), 1045-1048.  
 
Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, Hu FB. (2006) Low-
carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 
355(19), 1991-2002.  
 
Henry CJ, Lightowler HJ, Strik CM. (2007) Effects of long-term intervention with low- and 
high-glycaemic-index breakfasts on food intake in children aged 8-11 years. Br J Nutr. 98(3), 
636-640. 
 
Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, Goke B. (1995) Glucagon-like 
peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to 
nutrients. Digestion 56, 117-126.  
 
Hirschler V, Oestreicher K, Beccaria M, Hidalgo M, Maccallini G. (2008) Inverse 
Association between Insulin Resistance and Frequency of Milk Consumption in Low-Income 
Argentinean School Children. J Pediatr. [Epub ahead of print] 
 
Holt SH, Miller JC, Petocz P, Farmakalidis E. (1995) A satiety index of common foods. Eur 
J Clin Nutr. 49(9), 675-690. 
 
Holt SH, Brand-Miller JC, Petocz P. (1996) Interrelationships among postprandial satiety, 
glucose and insulin responses and changes in subsequent food intake. Eur J Clin Nutr 50(12), 
788-97. 
 
Holt SH, Miller JC, Petocz P. (1997) An insulin index of foods: the insulin demand generated 
by 1000-kJ portions of common foods. Am J Clin Nutr. 66(5), 1264-1276. 
 
Hoyt G, Hickey MS, Cordain L. (2005) Dissociation of the glycaemic and insulinaemic 
responses to whole and skimmed milk. British Journal of Nutrition 93, 175-177. 
 
Hunt JN, Knox MT. (1972) The slowing of gastric emptying by four strong acids and three 
weak acids. J Physiol 222(1), 187-208. 
 
Hunt JN, Smith JL, Jiang CL. (1985) Effect of meal volume and energy density on the gastric 
emptying of carbohydrates. Gastroenterology. 89(6), 1326-1330. 
 
Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S. (1986) The serum insulin 
and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) 
diabetic patients. Diabetologia 29(11), 784-91. 
52 
 
Gannon MC, Nuttall FQ. (1987) Factors affecting interpretation of postprandial glucose and 
insulin areas. Diabetes Care 10(6), 759-763. 
Gannon MC, Nuttall FQ, Neil BJ, Westphal SA. (1988) The insulin and glucose responses to 
meals of glucose plus various proteins in type II diabetic subjects. Metabolism 37(11), 1081-
1088. 
Gannon MC, Ercan N, Westphal SA, Nuttall FQ. (1993) Effect of added fat on plasma 
glucose and insulin response to ingested potato in individuals with NIDDM. Diabetes Care 
16(6), 874-880. 
Gregersen S, Rasmussen O, Winther E, Hermansen K. (1990) Water volume and 
consumption time: influence on the glycemic and insulinemic responses in non-insulin-
dependent diabetic subjects. Am J Clin Nutr. 52(3), 515-518. 
 
Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L, Riccardi G. (2000) 
Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural 
foods improves blood glucose control and reduces the number of hypoglycemic events in 
type 1 diabetic patients. Diabetes Care 23(10), 1461-1466. 
 
Gilbertson HR, Brand-Miller JC, Thorburn AW, Evans S, Chondros P, Werther GA. (2001) 
The effect of flexible low glycemic index dietary advice versus measured carbohydrate 
exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care. 24(7), 
1137-1143. 
 
Gregersen S, Rasmussen O, Winther E, Hermansen K. (1990) Water volume and 
consumption time: influence on the glycemic and insulinemic responses in non-insulin-
dependent diabetic subjects. Am J Clin Nutr. 52(3), 515-518. 
 
Gross LS, Li L. (2004) Increased consumption of refined carbohydrates and the epidemic of 
type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 79, 774-779. 
 
Järvi AE, Karlström BE, Granfeldt YE, Björck IE, Asp NG, Vessby BO. (1999) Improved 
glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic 
index diet in type 2 diabetic patients. Diabetes Care 22(1), 10-18. 
 
Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL, 
Axelsen M. (2002) Glycemic index: overview of implications in health and disease. Am J 
Clin Nutr 76(1), 266S-73S.  
 
Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, Lam Y, Mayer A, 
Thompson LU. (1987) Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr. 
46(6), 968-975. 
 
53 
Jenkins DJ, Wolever TM, Ocana AM, Vuksan V, Cunnane SC, Jenkins M, Wong GS, Singer 
W, Bloom SR, Blendis LM, Josse RG (1990) Metabolic effects of reducing rate of glucose 
ingestion by single bolus versus continuous sipping. Diabetes 1990 39 775-781. 
 
Jenkins DJ, Wolever TM, Taylor RH, Barker HM, Fielden H, Baldwin JM, Bowling AC. 
(1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin 
Nutr 34, 362-366. 
 
Joannic JL, Auboiron S, Raison J, Basdevant A, Bornet F, Guy-Grand B. (1997) How the 
degree of unsaturation of dietary fatty acids influences the glucose and insulin responses to 
different carbohydrates in mixed meals. Am J Clin Nutr. 65(5), 1427-33. 
 
Johnson RK, Frary C. (2001) Choose beverages and foods to moderate your intake of sugars: 
the 2000 dietary guidelines for Americans--what's all the fuss about? J Nutr. 131(10), 2766S-
2771S.  
 
Kabir M, Rizkalla SW, Quignard-Boulangé A, Guerre-Millo M, Boillot J, Ardouin B, Luo J, 
Slama G (1998) A high glycemic index starch diet affects lipid storage-related enzymes in 
normal and to a lesser extent in diabetic rats. J Nutr. 128(11), 1878-83. 
 
Kranz S, Smiciklas-Wright H, Siega-Riz AM, Mitchell D. (2005) Adverse effect of high 
added sugar consumption on dietary intake in American preschoolers. J Pediatr. 146(1), 105-
111.  
 
Laine DC, Thomas W, Levitt MD, Bantle JP. (1987) Comparison of predictive capabilities of 
diabetic exchange lists and glycaemic index of foods. Diabetes Care 10, 387-394. 
 
Lardinois CK, Starich GH, Mazzaferri EL, DeLett A. (1987) Polyunsaturated fatty acids 
augment insulin secretion. J Am Coll Nutr. 6(6), 507-515. 
 
Lavin JH, Wittert G, Sun WM, Horowitz M, Morley JE, Read NW. (1996) Appetite 
regulation by carbohydrate: role of blood glucose and gastrointestinal hormones. Am J 
Physiol. 271(2 Pt 1), E209-E214. 
 
Lawlor DA, Ebrahim S, Timpson N, Davey Smith G. (2005) Avoiding milk is associated 
with a reduced risk of insulin resistance and the metabolic syndrome: findings from the 
British Women's Heart and Health Study. Diabet Med. 22(6), 808-811.  
 
Lee BM, Wolever TM. (1998) Effect of glucose, sucrose and fructose on plasma glucose and 
insulin responses in normal humans: comparison with white bread. Eur J Clin Nutr 52(12), 
924-8. 
 
Lefèbvre PJ, Scheen AJ. (1998) The postprandial state and risk of cardiovascular disease. 
Diabet Med 15 Suppl 4, S63-8. 
 
54 
Lifeway Foods, Inc. (2005a) Lifeway kefir research reports. Available at: 
http://www.lifeway.net/research.php. Accessed September 30, 2008.  
 
Lifeway Foods, Inc. (2005b) Lifeway kefir product information. Available at: 
http://www.lifeway.net/product.php. Accessed November, 2008.  
 
Liljeberg HG, Lönner CH, Björck IM. (1995) Sourdough fermentation or addition of organic 
acids or corresponding salts to bread improves nutritional properties of starch in healthy 
humans. J Nutr. 125(6), 1503-1511. 
 
Liljeberg HG, Björck IM. (1996) Delayed gastric emptying rate as a potential mechanism for 
lowered glycemia after eating sourdough bread: studies in humans and rats using test 
products with added organic acids or an organic salt. Am J Clin Nutr. 64(6), 886-893. 
 
Liljeberg H, Björck I. (1998) Delayed gastric emptying rate may explain improved glycaemia 
in healthy subjects to a starchy meal with added vinegar. Eur J Clin Nutr 52(5), 368-371. 
 
Liljeberg H, Björck I. (2001) Milk as a supplement to mixed meals may elevate postprandial 
insulinaemia. Eur J Clin Nutr 55, 994-999. 
 
Liu S, Manson JE, Stampfer MJ, Holmes MD, Hu FB, Hankinson SE, Willett WC. (2001) 
Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-
density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal 
women. Am J Clin Nutr 73(3), 560-6. 
 
Livesey G, Taylor R, Hulshof T, Howlett J. (2008) Glycemic response and health--a 
systematic review and meta-analysis: relations between dietary glycemic properties and 
health outcomes. Am J Clin Nutr 87, 258S-268S.  
 
Lopitz-Otsoa F, Rementeria A, Elguezabal N, Garaizar J. (2006) Kefir: a symbiotic yeasts-
bacteria community with alleged healthy capabilities. Rev Iberoam Micol. 23(2), 67-74. 
 
Louis-Sylvestre J, Le Magnen J. (1980) A fall in blood glucose level precedes meal onset in 
free-feeding rats. Neurosci Biobehav Rev 4, 13-15. 
 
Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. (1999) High 
glycaemic index foods, overeating, and obesity. Pediatrics 103, E261-E266. 
 
Ludwig D (2000). Dietary glycaemic index and obesity. J Nutr 130, 280S-283S. 
 
Ludwig D (2002). The glycemic index: physiological mechanisms relating to obesity, 
diabetes, and cardiovascular disease. JAMA 287(18), 2414-23.  
 
Malik VS, Schulze MB, Hu FB. (2006) Intake of sugar-sweetened beverages and weight 
gain: a systematic review. Am J Clin Nutr. 84(2), 274-88.  
55 
 
Ma Y, Olendzki B, Chiriboga D, Hebert JR, Li Y, Li W, Campbell M, Gendreau K, Ockene 
IS. (2005) Association between dietary carbohydrates and body weight. Am J Epidemiol. 
161(4), 359-67. 
 
Ma Y, Olendzki BC, Merriam PA, Chiriboga DE, Culver AL, Li W, Hébert JR, Ockene IS, 
Griffith JA, Pagoto SL. (2008) A randomized clinical trial comparing low-glycemic index 
versus ADA dietary education among individuals with type 2 diabetes. Nutrition 24(1), 45-
56. 
 
Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, 
Ceriello A, Giugliano D. (1995) Glutathione reverses systemic hemodynamic changes 
induced by acute hyperglycemia in healthy subjects. Am J Physiol 268(6 Pt 1), E1167-
E1173. 
 
Marquina D, Santos A, Corpas I, Muñoz J, Zazo J, Peinado JM. (2002) Dietary influence of 
kefir on microbial activities in the mouse bowel. Lett Appl Microbiol. 35(2), 136-140. 
 
Marten B, Pfeuffer M, Schrezenmeir J. (2006) Medium-chain triglycerides. Int Dairy J. 16, 
1374-1382. 
 
Mayer J. (1953) Glucostatic mechanism of regulation of food intake. N Engl J Med 249(1), 
13-16.  
 
Mayes PA. (1993) Intermediary metabolism of fructose. Am J Clin Nutr 58(5 Suppl), 754S-
765S.  
 
Melanson KJ, Westerterp-Plantenga MS, Saris WH, Smith FJ, Campfield LA. (1999) Blood 
glucose patterns and appetite in time-blinded humans: carbohydrate versus fat. Am J Physiol. 
277(2 Pt 2), R337-45. 
 
Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. (1998) Effect of physical exercise on 
sensitivity and responsiveness to insulin in humans. American Journal of Physiology 254, 
E248-59. 
 
Moghaddam E, Vogt JA, Wolever TM. (2006) The effects of fat and protein on glycemic 
responses in nondiabetic humans vary with waist circumference, fasting plasma insulin, and 
dietary fiber intake. J Nutr. 136(10), 2506- 2511.  
 
Moore MC, Cherrington AD, Mann SL, Davis SN. (2000) Acute fructose administration 
decreases the glycemic response to an oral glucose tolerance test in normal adults. J Clin 
Endocrinol Metab 85(12), 4515-4519. 
 
Morgan L. (1992) Insulin secretion and the entero-insular axis. In: Flatt PR, ed. Nutrient 
regulation of insulin secretion. London: Portland press Ltd, 1-22. 
56 
 
Muoio DM, Newgard CB. (2006) Obesity-related derangement in metabolic regulation. 
Annual Review of Biochemistry 75, 367-401. 
 
Nielsen SJ, Popkin BM. (2004) Changes in beverage intake between 1977 and 2001. Am J 
Prev Med. 27(3), 205-210.  
 
Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IM. (2004) Glycemia and insulinemia in 
healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of 
plasma amino acids and incretins. Am J Clin Nutr. 80(5), 1246-1253. 
 
Nuttall FQ, Gannon MC. (1991) Plasma glucose and insulin response to macronutrients in 
nondiabetic and NIDDM subjects. Diabetes Care 14(9), 824-838.  
 
Nuttall FQ, Mooradian AD, Gannon MC, Billington C, Krezowski P. (1984) Effect of protein 
ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes 
Care 7(5), 465-70. 
 
Oberle RL, Chen TS, Lloyd C, Barnett JL, Owyang C, Meyer J, Amidon GL. (1990) The 
influence of the interdigestive migrating myoelectric complex on the gastric emptying of 
liquids. Gastroenterology. 99(5), 1275-1282. 
 
Ostman EM, Liljeberg Elmståhl HG, Björck IM. (2001) Inconsistency between glycemic and 
insulinemic responses to regular and fermented milk products. Am J Clin Nutr 74(1), 96-100. 
 
Otto H & Niklas L. (1980) Différences d’action sur la glycémie d’aliments contenant des 
hydrates de carbone. Conséquences pour le traitement diététique du diabète sucré. Med Hyg 
38, 3424-3429. 
 
Owen B, Wolever TMS. Effect of fat on glycaemic response in normal subjects: a dose-
response study. Nutr Res. 23, 1341-1347. 
 
Parks EJ, Skokan LE, Timlin MT, Dingfelder CS. (2008) Dietary sugars stimulate fatty acid 
synthesis in adults. J Nutr. 138(6), 1039-1046. 
 
Pawlak DB, Ebbeling CB, Lugwig DS. (2002) Should obese patients be counseled to follow 
a low-glycaemic index diet? Yes. Obes Rev 3, 235-243. 
 
Pawlak DB, Kushner JA Ludwig DS (2004) Effects of dietary glycaemic index on adiposity, 
glucose homoeostasis, and plasma lipids in animals. Lancet 364(9436), 778-85.  
 
Pennington JA. (1998) Bowes & Church’s food values of portions commonly used. 
Lippincott Press:Philadelphia, PA. 
 
57 
Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. (2002) 
Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the 
CARDIA Study. JAMA 287(16), 2081-2089.  
 
Perusse L, Bouchard C. (2000) Gene-diet interactions in obesity. Am J Clin Nutr 72, 1285S–
1290S. 
 
Pfeuffer M, Schrezenmeir J. (2007) Milk and the metabolic syndrome. Obes Rev. 8(2), 109-
118. 
 
Pirozzo S, Summerbell C, Cameron C, Glasziou P. (2003) Should we recommend low-fat 
diets for obesity? Obes Rev 4, 83-90. 
 
Robert SB. (2000) High-glycemic index foods, hunger, and obesity: is there a connection? 
Nut Rev 58(6), 163-169. 
 
Roberts SB. (2000) High-glycemic index foods, hunger, and obesity: is there a connection? 
Nutr Rev 58, 163-169. 
 
Roberts M, Yarunin S. (2000) Danone moves into Russian kefir market. New Nutr Business 
6, 22-24.  
 
Rolls BJ, Hetherington M, Burley VJ. (1988) The specificity of satiety: the influence of 
foods of different macronutrient content on the development of satiety. Physiol Behav. 43(2), 
145-153. 
 
Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, 
Wing AL, Willett WC (1997a) Dietary fiber, glycaemic load, and risk of NIDDM in men. 
Diabetes Care 20, 545-550. 
 
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. (1997b) Dietary 
fiber, glycaemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 
277, 472-477. 
 
Sanggaard KM, Holst JJ, Rehfeld JF, Sandström B, Raben A, Tholstrup T. (2004) Different 
effects of whole milk and a fermented milk with the same fat and lactose content on gastric 
emptying and postprandial lipaemia, but not on glycaemic response and appetite. Br J Nutr. 
92(3), 447-459. 
 
Schmid R, Schusdziarra V, Schulte-Frohlinde E, Maier V, Classen M. (1989) Role of amino 
acids in stimulation of postprandial insulin, glucagon, and pancreatic polypeptide in humans. 
Pancreas. 4(3), 305-314. 
 
Sheppard L, Kristal AR, Kushi LH. (1991) Weight loss in women participating in a 
randomized trial of low-fat diets. Am J Clin Nutr. 54(5), 821-8. 
58 
 
Simpson RW, McDonald J, Wahlqvist ML, Atley L, Outch K. (1985) Macronutrients have 
different metabolic effects in nondiabetics and diabetics. Am J Clin Nutr. 42(3), 449-453. 
 
Smith FJ, Campfield LA. (1993) Meal initiation occurs after experimental induction of 
transient declines in blood glucose. Am J Physiol 265, R1423-R1429. 
 
Snijder MB, van Dam RM, Stehouwer CD, Hiddink GJ, Heine RJ, Dekker JM. (2008) A 
prospective study of dairy consumption in relation to changes in metabolic risk factors: the 
Hoorn Study. Obesity (Silver Spring). 16(3), 706-709.  
 
Southgate DAT. (1976) Determination of food carbohydrates. London: Applied Science.  
 
Steiner G, Lewis G. (1996) Hyperinsulinemia and triglyceride-rich lipoproteins. Diabetes 45, 
S24-S26. 
 
Stephan T, Nolan S, Khurana RC, Morgan CR, Wingert JP, Danowski TS. (1972) Lag 
glucose tolerance curves. Am J Med Sci. 264(1), 41-7. 
 
Stout R. (1996) Hyperinsulinemia and atherosclerosis. Diabetes 45, S45-S46.  
 
Strandhagen E, Lia A, Lindstrand S, Bergstrom P, Lundstrom A, Fonden R & Andersson H 
(1994) Fermented milk (ropy milk) replacing regular milk reduces glycaemic responses and 
gastric emptying in healthy subjects. Scand J Nutr/Naringsforskning 38, 117-121. 
 
Stubbs RJ. (1995) Macronutrient effects on appetite. Int J Obes Relat Metab Disord. 19 
Suppl 5, S11-19. 
 
Stubbs RJ, Hughes DA, Johnstone AM, Rowley E, Reid C, Elia M, Stratton R, Delargy H, 
King N, Blundell JE. (2000) The use of visual analogue scales to assess motivation to eat in 
human subjects: a review of their reliability and validity with an evaluation of new hand-held 
computerized systems for temporal tracking of appetite ratings. Br J Nutr. 84(4), 405-415.  
 
Title LM, Cummings PM, Giddens K, Nassar BA. (2000) Oral glucose loading acutely 
attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect 
prevented by vitamins C and E. J Am Coll Cardiol 36(7), 2185-2191. 
 
Thompson DG, Wingate DL, Thomas M, Harrison D. (1982) Gastric emptying as a 
determinant of the oral glucose tolerance test. Gastroenterology 82, 51-55. 
 
Todesco T, Rao AV, Bosello O, Jenkins DJ. (1991) Propionate lowers blood glucose and 
alters lipid metabolism in healthy subjects. Am J Clin Nutr 54(5), 860-865. 
 
59 
Torsdottir I, Blomqvist R, Ekman R, Hagander B, Sandberg A-S. (1992) Fermented or fresh 
vegetables decrease the postprandial blood glucose and insulin levels in healthy persons. 
Scand J Nutr 36, 4-7. 
 
Van Amelsfort JMM. (1989) Effects of varying the carbohydrate: fat ratio in a hot lunch on 
postprandial variables in male volunteers. British Journal of Nutrition 61, 267-283 
 
van Amelsvoort JM, Weststrate JA. (1992) Amylose-amylopectin ratio in a meal affects 
postprandial variables in male volunteers. Am J Clin Nutr. 55(3), 712-718. 
 
Vega-López S, Ausman LM, Griffith JL, Lichtenstein AH. (2007) Interindividual variability 
and intra-individual reproducibility of glycemic index values for commercial white bread. 
Diabetes Care. 30(6), 1412-1417.  
 
Vegarud GE, Langsrud T, Svenning C. (2000) Mineral-binding milk proteins and peptides; 
occurrence, biochemical and technological characteristics. Br J Nutr. 84 Suppl 1, S91-98.  
 
WHO/FAO. (1998) Carbohydrates in human nutrition. Report of a Joint FAO/WHO Expert 
Consultation, WHO: Geneva  FAO Food Nutritional Paper 66, 1-140. 
 
Wild S, Roglic G,Green A, Sicree R, King H. (2004) Global prevalence of diabetes: 
estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053. 
 
Wolever TMS, Jenkins DJA, Jenkins AL, Josse RG, Wong GS, Lee R. (1987) The glycemic 
index: similarity of values derived in insulin-dependent and non-insulin-dependent diabetic 
patients. J Am Coll Nutr. 6(4), 295-305. 
 
Wolever TMS, Jenkins DJA, Jenkins AL, Josse RG. (1991) The glycaemic index: 
methodology and clinical implications. American Journal of Clinical Nutrition 54, 846-854. 
 
Wolf BW, Humphrey PM, Hadley CW, Maharry KS, Garleb KA, Firkins JL. (2002) 
Supplemental fructose attenuates postprandial glycemia in Zucker fatty fa/fa rats. J Nutr 
132(6), 1219-1223. 
 
Wolever TMS, Bolognesi C. (1996) Time of day influences relative glycaemic effect of 
foods. Nutrition Research 16, 381-384. 
 
Wolever TMS,Vorster HH, Bjork I, Brand-Miller J, Brighenti F. Mann JL, Ramdath DD, 
Granfeldt Y, Holt S, Perry TL, Venter C, Wu X. (2003) Determination of the glycaemic index 
of foods: interlaboratory study. European Journal of Clinical Nutrition 57, 475-482.  
 
 
 
60 
EFFECTS OF KEFIRS ON GLYCEMIC, INSULINEMIC AND 
SATIETY RESPONSES 
A paper to be submitted to British Journal of Nutrition 
Kai Ling Kong, Suzanne Hendrich 
ABSTRACT 
We hypothesized that three types of kefir (Lifeway® Low Fat Strawberry Kefir, 
ProBugs Kefir, orange flavor, and Lifeway® Low Fat Plain Kefir) would have low glycemic 
index (GI), high insulinemic index (II) and high satiety index (SI). Secondarily, we 
hypothesized that there would be no significant correlations among postprandial satiety, 
glucose and insulin responses. Lastly, we hypothesized that kefir, like other dairy products, 
would have dissociation of GI and II. To test our hypotheses, this study was divided into 
three phases. In Phase I, a portion of Lifeway® Low Fat Strawberry Kefir (S group) and a 
portion of ProBugs Kefir, orange flavor (O group) containing 50 g of available carbohydrates 
were tested.  In Phase II, a portion of Lifeway® Low Fat Plain Kefir (P group) containing 25 
g of available carbohydrates were tested. In Phase III, 240-kcals portions of all three types of 
kefirs were tested. In all phases a single meal, randomized crossover design was performed in 
which the test meals were fed to 10 healthy, male and female adults. The total glucose AUC 
of S group (p< 0.0023), O group (p< 0.0002) and P group (p< 0.0002) were significantly 
lower compared with their respective glucose controls. A slight, but not significant inverse 
relationship between glycemic and satiety responses was observed with kefir beverages (r = -
0.87; P = 0.13). Using a variance of component analysis, it was found that a significant 
relationship between the correlated effects of the treatments on GI and SI can be further 
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tested in the future by increasing the number of subjects to 12. Like other dairy products, 
kefir showed a dissociation of GI and II.  Kefir can potentially be a useful food choice for 
patients with diabetes who are required to control their blood glucose levels. 
 
Keywords: kefir, glycemic index, insulinemic index, satiety index 
 
INTRODUCTION 
 According to the World Health Organization (WHO), by 2015 an estimated 2.3 
billion adults will be overweight [Body Mass Index (BMI) of ≥ 25 kg/m2], and more than 
700 million will be obese (BMI of ≥ 30 kg/m2) (2008a). Obesity greatly affects the overall 
quality of life. It is the major contributor for chronic diseases such as: type 2 diabetes, 
cardiovascular disease, hypertension, strokes and some types of cancer (WHO/FAO, 1998; 
Wild et al., 2004; 2008a). When the per capita nutrient consumption in the United States, 
between 1909 and 1997 was compared with the prevalence of type 2 diabetes, Gross and 
colleagues observed a strong correlation between the consumption of refined carbohydrates 
and the prevalence of type 2 diabetes (Gross et al., 2004). Therefore, carbohydrates, in terms 
of both quantity and of quality, are receiving significant attention in current laboratory and 
clinical studies. 
 Glycemic index (GI) was first introduced by Jenkins and colleagues in 1981 to assess 
and classify different carbohydrate-rich foods according to their effects on postprandial 
glycemia (Jenkins et al., 1981). The original purpose of the GI was to provide additional 
information to help patients with diabetes to better control their blood glucose levels. Low-GI 
foods cause a smaller insulin response and a slower release of glucose into the bloodstream 
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compared with high-GI foods. Later studies have shown that high-GI diets are independently 
associated with an increased risk of developing obesity, type 2 diabetes, cardiovascular 
disease, insulin resistance, and cancer (Livesey et al., 2008). As a result, a great deal of 
attention has been focused on the health benefits of consuming low-GI diets.  
 Generally speaking, dairy products have low GI values. Based on the 2002 
International Table of Glycemic Index and Glycemic Load Values, four types of dairy 
products were tested for GI: ice cream, GI = 61 (regular, mean of five studies); milk, GI = 27 
(full-fat, mean of five studies); milk, GI = 32 (skim, one study); fermented milk, GI = 11 (3% 
fat, mean of two studies) and yogurt, GI = 14-38 (from lower value for non caloric sweetener 
to higher value for caloric sweetener, nonfat to low fat, range of 14 studies) (Foster-Powell et 
al., 2002). Our study is interested in kefir, the type of milk product that is commonly used in 
most Eastern Europe countries. Until the present time, no study has measured the GI of kefir. 
Today, kefir is becoming increasingly popular. Some researchers believe that the various 
health-promoting properties of kefir outweigh those of yogurt (Lopitz-Otsoa et al., 2006). 
With the increase of diabetes worldwide, it is worth examining if kefir can bring positive 
effects in helping to combat this pandemic disease.  
 Most of the foods tested for GI values have not been measured for their concurrent 
postprandial insulinemic responses. According to Del Prato et al. (1994), chronic, 
physiologic hyperinsulinemia can lead to the development of insulin resistance. Besides that, 
hyperinsulinemia is one of the risk factors in the development of many diseases, such as 
obesity, diabetes, cancer and dyslipidemia ((DeFronzo et al., 1991; Brouns et al., 2005).  
While the measurement of postprandial blood glucose responses is important, the 
measurement of postprandial insulinemic responses is equally important. The concept of 
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insulin index (II) of foods generated by 1000-kJ (240-kcals) was developed by Holt et al. 
(1997) in order to systematically rate the postprandial insulinemic responses of different type 
of foods. II is calculated in the same fashion as the GI. The II of different type of kefir drinks 
will be measured in this study. 
 In general, pure carbohydrates, sugars and starchy foods have a high correlation 
between glycemic and insulinemic responses (Lee et al., 1998). However, studies have 
shown that non-starchy foods can produce higher insulin responses than expected from their 
GI (Gannon et al., 1988; Holt et al., 1997; Ostman et al., 2001). This is because 
carbohydrates are not the only stimulus for insulin secretion. There are a number of 
insulinotropic factors that mediate postprandial insulin secretion including fructose, certain 
amino acids, fatty acids, and gastrointestinal hormones such as gastric inhibitory peptide, 
glucagon, and cholecystokinin (Nuttall et al., 1991; Morgan, 1992).  Most recently, milk 
products were shown to elicit unexpectedly high insulin AUCs compared with the predicted 
insulin AUCs from their GI values (Ostman et al., 2001; Liljeberg et al., 2001). For example, 
in Ostman et al.’s study, they tested one type of regular milk and two types of fermented 
milk: ropy milk and filmjolk by using white bread as the standard. The GI values for all three 
milk products were very low, ranging from 12 to 30; however, the II values were very high 
relative to their GIs (reported to be similar with the reference meal’s value). Kefir is a kind of 
fermented milk product, which is somewhat similar with ropy milk and filmjolk. Therefore, 
the present study is interested in examining the relationship of GI and II of kefir and to 
further confirm the finding of Ostman et al., which is the dissociation of GI and II of dairy 
products.  
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 Varied postprandial metabolic events elicited by high GI and low GI diets are 
hypothesized to have potential effects on satiety (Holt et al., 1995). Many studies have been 
conducted to examine the relationship between glycemic index and satiety. However, the 
results of the studies are inconsistent. Some found no effect of GI on satiety and food intake, 
while others found a significant suppression of hunger and appetite after consumption of the 
low GI diets (Bornet et al., 2007). In 1995, Holt and colleagues saw the need for developing 
a system to produce a table that could demonstrate the energy-satiety ratio of a list of 
common foods; thus, introducing the concept of satiety index (SI) (Holt et al., 1995). Holt et 
al. believed that energy-equivalent loads of the different nutrients can have different effects 
of satiety, thermogenesis, carbohydrate storage and fat storage. Even though a number of 
studies have shown different types of nutrients and foods satisfy hunger to varying extents, 
we still have a limited understanding of the complex interacting mechanisms of satiation 
(Holt et al., 1995). One purpose of the present study is to measure the satiety index of kefir 
drinks. We are interested in knowing the SI score (%) of kefir compared with the list of 38 
foods tested by Holt et al. on an isoenergetic basis. Moreover, in a later publication, Holt et 
al. used the SI scores (%) of 38 foods to determine whether the postprandial increments in 
subjective satiety, plasma glucose and insulin responses were interrelated (Holt et al., 1996). 
This is because Holt and colleagues believed that postprandial increments in plasma glucose 
and/or insulin are likely to be among the physiological mechanisms responsible for the 
satiating effects of foods. Therefore, our study is also designed to determine the 
interrelationships among postprandial satiety, glucose and insulin responses. 
The objective of this study was to produce a glycemic, insulinemic and satiety 
indexes of three type of kefir (Lifeway® Low Fat Strawberry Kefir, ProBugs Kefir, orange 
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flavor, and Lifeway® Low Fat Plain Kefir). The hypothesis tested was that all of the kefir 
beverages would have low GI, high II and high SI values. In order to test our hypothesis, the 
study was divided into three phases. A portion of Lifeway® Low Fat Strawberry Kefir and a 
portion of ProBugs kefir, orange flavor containing 50 g of available carbohydrates were fed 
to 10 healthy subjects in Phase I. A portion of Lifeway® Low Fat Plain Kefir containing 25 g 
of available carbohydrates was fed to 10 healthy subjects in Phase II. A 240-kcal portion of 
all three types of kefirs were fed to 10 healthy subjects in Phase III. Glucose solution was 
used as the reference food in Phase I and Phase II, and white bread was used in Phase III. 
Secondarily, we hypothesized that there were no significant correlations among postprandial 
satiety, glucose and insulin response. Lastly, we hypothesized that kefir, like other dairy 
products, would have dissociation of GI and II.  
 
SUBJECTS AND METHODS 
Study Design 
 The study was a randomized crossover study with a minimum of 4-day washout 
period between each treatment visit. It was divided into three phases.  
In phase I, the glycemic index of Lifeway® Low Fat Strawberry Kefir (S group), and 
Lifeway ProBugs Kefir (orange flavor) (O group) were measured. Subjects were required to 
consume portions of these two types of kefir containing 50 g of available carbohydrates, and 
two glucose reference solutions (50 g dextrose in 296 mL volume, Fisherbrand Sun-Dex, 
Fisher Health Care, Houston, TX) for a total of four treatment visits. 
In phase II, the glycemic index of Lifeway® Low Fat Plain Kefir (P group) was 
measured. Subjects were required to consume portions of Lifeway® Low Fat Plain Kefir 
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containing 25 g of available carbohydrate, and two glucose reference solutions (25 g dextrose 
in 148 mL volume, Fisherbrand Sun-Dex, Fisher Health Care, Houston, TX) for a total of 
three treatment visits. This reduction in carbohydrates from 50 g to 25 g is necessary because 
the low carbohydrate content of plain kefir would necessitate the feeding of an excessive 
amount of kefir (>1 L) to achieve 50 g carbohydrate intake. It is a very unrealistic portion 
size and the subjects would not be able to finish it in a short amount of time (15 minute time 
limit). 
In phase III, insulin and satiety index of the same beverages (Lifeway kefir- low fat 
plain kefir, low fat strawberry kefir and ProBugs orange flavor kefir) were measured. 
However, white bread (as opposed to glucose solution) was used as the reference food and 
the portion sizes of the test and reference foods were standardized by energy content, not 
carbohydrate content. This is because nutrients other than carbohydrate can stimulate insulin 
secretion (Holt et al., 1997) and energy content is a key variable that affects satiety (Holt et 
al., 1995). Subjects were required to consume 240-kcal (1000-kJ) portions of the white bread 
and each type of kefir.  
Test meals 
Table 1 shows the portion sizes of three type of kefir required to provide 25 g or 50 g 
available carbohydrates for Phase I and II of the study and their individual nutrient 
composition. The reference food of these two phases was 25 g (148 mL) or 50 g dextrose 
(296 mL), Fisherbrand Sun-Dex, Fisher Health Care, Houston, TX respectively. For phase 
III, subjects were required to consume 240-kcal (1000-kJ) portions of each type of kefir 
(Lifeway® Low Fat Strawberry Kefir, ProBugs kefir, orange flavor, and Lifeway® Low Fat 
Plain Kefir). Table 2 shows the portion sizes of the kefir drinks and their individual nutrient 
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compositions. The reference food of this phase was 240-kcal of Sara Lee® White Bread. In 
each phase, subjects were given 4 oz (~118 mL) of water to help with ingestion. All of the 
nutrient composition and the feeding portion sizes are derived from the product labels. 
Subjects 
 A study protocol was approved by the Iowa State University Human Subject 
Protection Committee. Individuals who showed interest were invited to the Iowa State 
University, Nutrition and Wellness Research Center for screening tests. Those who were 
recruited to be the subjects of the study were healthy adults, ages 18-45 years, with no history 
of diabetes, glucose intolerance, gastrointestinal disorders or use of tobacco. Their fasting 
plasma glucose concentrations were less than 100 mg/dL and their body mass index were less 
than 30 kg/m². They were also interviewed and completed detailed questionnaires on medical 
conditions, use of medications or dietary supplements that could affect glucose tolerance.  
 A total of 30 subjects were recruited for this study. Relevant characteristics of the 
subjects are listed in Table 3. For the female subjects, none showed positive results for the 
pregnancy tests. These 30 subjects were divided into three groups for three phases of the 
study. Phase I comprised of five males and five females with a mean age (± standard error of 
the mean) of 22 ± 2 years, mean BMI of 22.2 ± 3.4 kg/m2 and mean fasting plasma glucose 
level of 88 ± 6 mg/dL. Phase II comprised of five males and five females with a mean age of 
23 ± 3 years, mean BMI of 22.6 ± 3.0 kg/m2 and mean fasting plasma glucose level of  91 ± 
4 mg/dL. Phase III comprised of fives male and five females with a mean age of 25 ± 4 
years, mean BMI of 24.2 ± 3.5 kg/m2 and mean fasting plasma glucose level of 93 ± 5 
mg/dL. Due to an error during blood collection, the insulin and glucose AUC for O group in 
Phase III of the study was calculated from nine subjects instead of ten subjects. 
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Feeding protocol 
 Three days prior to each visit, subjects were asked to consume at least 150 g per day 
of carbohydrates and record them in a 3-days dietary food record. Subjects were required to 
fast eight to ten hours overnight before for the meal tolerance test. They also had to refrain 
from vigorous exercise for 12 hours before the visit (Brouns et al., 2005).  
 Subjects arrived at the Iowa State University, Nutrition and Wellness Research Center 
(NWRC) between 0700 and 0730 hour. Upon their arrival, the subjects’ body weight was 
measured and there was a 30-minute resting period to allow stabilization of blood glucose. 
During the resting period, the 3-day dietary records were analyzed for carbohydrate intake by 
using Nutritionist V diet analysis software. After the rest period, a baseline blood sample 
(approximately 1-2 mL) was obtained by a capillary finger-stick. Then the subject preceded 
to the dining area for the test meals. The order of the test meals was randomized. Subjects 
were directed to consume the required portion of either the test or reference meals within 15 
minutes. The timing for the meal tolerance test started with the first sip or first bite of their 
meal. Subjects resumed fasting after consuming the meal and subsequent capillary finger-
stick blood samples were obtained at 15, 30, 45, 60, 90, and 120 min. Subjects were allowed 
to resume their normal diet and physical activity patterns after collection of the last blood 
sample. 
 In Phase III, in addition to all the meal tolerance test procedures as described above, 
subjects in this phase were required to provide self-reported feelings of satiety on an 
equilateral seven-point rating scale (see Figure 1) before each of the blood sampling time 
points (Holt et al. 1995). This scale was anchored 1 (extremely hungry) to 7 (extremely full). 
Subjects did not discuss or compare their hunger ratings with each other. 
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Analysis of plasma glucose and insulin concentrations  
 Blood samples were collected at 0, 15, 30, 45, 60, 90, and 120 minute time points.  
The whole blood samples (approximately 1-2 mL) were collected in 1.5 mL micro-centrifuge 
tubes. Samples were then centrifuged at 16, 000 relative centrifugal force (rcf) x g for 15 
minutes at 4 °C to obtain serum. Serum was stored frozen at -80 °C until it was thawed for 
analysis. Serum glucose concentrations were determined in duplicate using the glucose 
analyzer (Beckman Coulter Glucose Analyzer 2; Beckman Coulter Inc, Fullerton, CA) for 
Phase I and II and biochemical analyzer (YSI Model 2700 Select Biochemical Analyzer; 
Yellow Springs Instrument Co. Inc, Yellow Springs, OH) for Phase III.  Insulin concentrations 
in the serum were determined in duplicate using an enzyme-linked immunoassay (ALPCO 
Insulin EIA). 
Analysis of carbohydrate content of Lifeway® Kefir 
1.00 mL of each type of kefir drink was put into 1.5 mL micro-centrifuge tubes. The 
samples were then centrifuged at the speed of 16,000 rcf x g for 15 minutes at 4 °C. After 
centrifugation, the supernatant of each sample was transferred into a clean 1.5 mL micro-
centrifuge tube for glucose, sucrose and lactose analysis using the biochemical analyzer kits 
that have been validated by YSI Inc. (Yellow Spring, OH).  
Statistical analysis 
The AUC was calculated via the trapezoidal rule with fasting levels as the baseline 
and truncated at zero. Any negative area was ignored (Wolever et al. 1991). The formula for 
glycemic index (GI), glycemic, insulinemic index (II) and satiety index (SI) scores are as 
follows: 
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A glycemic score was used instead of glycemic index score in Phase III because the portion 
sizes of the meals were standardized by energy content (240-kcal), not carbohydrate content. 
As shown in Table 2, carbohydrate contents in all three kefir drinks were varied in Phase III. 
For the satiety index score, a group average was used instead of the individuals’AUC 
for reference food because there was one subject who experienced no satiety from the white 
bread and therefore gave a zero value to the denominator for the formula.  
AUC for glycemic, insulinemic and satiety and all of the three indexes (GI, II and SI) 
were analyzed by crossover ANOVA. Significance was defined as P<0.05. For the response 
variable in each phase, a carryover effect was first tested after adjusting for gender, sequence, 
period and treatment effects. If the carryover effect was not significant, the carryover terms 
were removed from the model before all other effects (gender, sequence, period and 
treatment) were tested. A Tukey-Kramer adjustment was used for multiple pair wise 
comparisons among treatments. Equal variance and normality assumption were checked 
using residual versus predicted values plot, and histogram of residuals respectively for each 
model.  
To find the sample size needed to observe a significant correlation between GI and SI 
the ratio of the covariance and product of the standard deviations was calculated for different 
AUC of the 0 to 120 min period 
for the test food 
 
Individual AUC of the 0 to 120 
min period for the reference food 
 
X 100 
71 
values of N. The covariance of the population means was estimated by the covariance of the 
sample means since independent errors were assumed. The variance of GI and SI were 
estimated using a variance components analysis for the data on GI and SI.   
T-tests were also used to test for differences between the actual and predicted GI 
values of all Lifeway® Kefir beverages. 
 
RESULTS 
 The models for all phases including carryover terms showed there was no significant 
carryover effect (P-value > 0.5), so carryover terms were removed from the final model for 
all phases. There were no significant gender, sequence and period effects when they were 
tested in all phases. 
Phase I: Glycemic responses of Lifeway® Low Fat Strawberry Kefir, and Lifeway 
ProBugs Kefir (Orange Flavor) 
The serum glucose responses to Lifeway® Low Fat Strawberry Kefir (S group), and 
Lifeway ProBugs Kefir (orange flavor) (O group) are shown in Figure 2 and Table 4. The 
total blood glucose AUC of subjects consuming strawberry-flavored kefir (S group, p< 
0.0023) and orange-flavored kefir (O group, p< 0.0002) was significantly lower compared 
with the reference meal (50 g of glucose solution). Total AUC for O group was not 
significantly different compared with S group. The GI of strawberry-flavored kefir was 60 ± 
10, which was significantly lower than the reference meal (GI = 100 ± 0); the GI of orange-
flavored kefir was 48 ± 10, which was significantly lower than the reference meal (Table 7).  
Phase II: Glycemic response of Lifeway® Low Fat Plain Kefir 
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 The serum glucose response to Lifeway® Low Fat Plain Kefir (P group) is shown in 
Figure 3 and Table 5. P group showed a significantly lower total glucose AUC compared 
with the reference meal (glucose solution, p< 0.0002). The GI of P group was 36 ± 9, which 
was significantly lower than the reference meal (GI = 100 ± 0) (Table 7). 
Phase III: Glucose, insulin and satiety responses of Lifeway® Low Fat Strawberry 
Kefir, Lifeway ProBugs Kefir (Orange Flavor), and Lifeway® Low Fat Plain Kefir 
 The insulinemic and satiety index values of Lifeway® Low Fat Strawberry Kefir were 
142 ± 48 and 85 ± 19 respectively, Lifeway ProBugs Kefir (orange flavor) were 124 ± 47 and 
121 ± 27 respectively and Lifeway® Low Fat Plain Kefir were  112 ± 36 and 122 ± 16 
respectively. Glycemic scores, insulinemic index and the satiety index were not significantly 
different among all the treatments and reference meal (white bread) (Table 6b). In term of the 
interrelationships among glucose, insulin and satiety responses, there were no significant 
correlations between the glycemic and satiety index scores (r = -0.87; P = 0.13) or 
insulinemic index and satiety index scores (r = -0.44; P = 0.56). However, by performing a 
variance of components analysis and calculating the covariance between the means of the 
treatments for GI and SI, the correlation between GI and SI was predicted to be -0.96 if there 
were 12 subjects in the study, assuming subjects similar to those in the present study.  Thus, 
an N of 12 would be proposed for future work on the satiety index of kefirs. 
Dissociation between glycemic index and insulinemic index of kefir  
 Table 7 is a summary of GI and II of three type of kefir from all the phases. As 
mentioned above, the GI of S, O and P groups were significantly lower than those after the 
control meals. No differences in GI were found between S group and O group. Even though 
there were differences of GI between kefir beverages and the control meals, the insulinemic 
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indexes for all the kefir beverages did not differ significantly from those for the control; 
indeed they were higher than the reference meal. No differences in insulinemic indexes were 
found among the beverages. These results showed that the blood insulin responses were not 
proportional to blood glucose responses after consuming the kefir beverages. With higher 
insulin released, kefir might have an insulinotropic effect after ingestion.  
Different types of carbohydrates content in Lifeway® Kefir 
The amount of glucose, sucrose and lactose content in Lifeway® Low Fat Strawberry 
Kefir, Lifeway ProBugs Kefir (orange flavor) and Lifeway® Low Fat Plain Kefir were 
measured. Table 8 shows the amount of each type of carbohydrate contained in all three 
beverages. In 546 mL of Lifeway® Low Fat Strawberry Kefir, there were 13.2 g of glucose, 
0.3 g of sucrose and 35.9 g of lactose; in 548 mL of Lifeway ProBugs Kefir (orange flavor), 
there were 3.1 g of glucose, 28.7 g of sucrose and 35.5 g of lactose; in 667 mL of Lifeway® 
Low Fat Plain Kefir, there were 0.1 g of glucose, 0 g of sucrose and 47.5 g of lactose.  
Actual and predicted glycemic indexes of Lifeway® Kefir 
 By using the data from the carbohydrate analysis of Lifeway® Kefir, the predicted 
glycemic indexes of all three types of kefir were determined using the GI mixed meals 
calculation method (Wolever et al., 1986). Table 10 shows the actual and predicted GI 
values. By running a t-test, it was found that there was no significant difference between the 
actual and predicted GI values for all of the beverages (S group, p-value = 0.4602; O group, 
p-value = 0.1587; P group, p-value = 0.1335). 
DISCUSSION 
 Based on the classification of GI value by Brand-Miller (1998), the results of present 
study showed that Lifeway® Low Fat Strawberry Kefir is a medium GI food (GI = 60). 
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Lifeway ProBugs Kefir (orange flavor) (GI = 48) and Lifeway® Low Fat Plain Kefir (GI = 
36) are low GI foods. By observing the ingredient information on the food labels, we believe 
the reason Lifeway® Low Fat Plain Kefir had the lowest GI value was because it did not 
contain any added sweeteners. On the other hand, both Lifeway® Low Fat Strawberry Kefir 
and Lifeway ProBugs Kefir (orange flavor) have added cane juice and juice concentrate in 
order to give desirable taste and flavor. Cane juice (cane sugar) mainly consists of sucrose 
(glucose α-1,2 fructose), a disaccharide and some glucose. The GI value for sucrose is 68 by 
using glucose as standard (Lee et al., 1998). The carbohydrate analysis which was done on all 
three types of Lifeway® beverages confirmed our assumption. The data showed that both 
strawberry and orange flavored kefir contained glucose and sucrose but not plain kefir. Dairy 
products generally have a GI value ranging from 11 to 36 (Foster-Powell et al., 2002); 
however, sweetener can increase the GI value of dairy products which are otherwise a low GI 
food.  
 The reason we used 25 g of carbohydrates in Phase II was to provide a realistic 
portion size of meals to the subjects. Plain kefir is a low carbohydrate content food, therefore 
it would necessitate the feeding of an excessive amount of kefir (>1 L) to achieve 50 g 
carbohydrate intake. According to the Glycemic Index Methodology of Brounds, 25 g of 
carbohydrate load is permitted to apply for GI test, but at the same time, the reference meal 
must be reduced to 25 g of carbohydrates. In addition, Lee and Wolever’s study showed that 
the mean glucose AUC increased linearly as the dose of carbohydrates increased. In other 
words, when the amount of carbohydrate intake is increased, the glucose response AUC will 
increase in a dose-response fashion (Lee and Wolever, 1998). However, our study did not 
show this dose-response fashion. When 50 g dextrose in 296 mL volume was fed to the 
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subjects in phase I, the total AUC of this control is 3272 ± 229 mg x min/dL; while when 25 
g dextrose in 148 mL volume was fed to the subjects in phase II, the total AUC of this 
control was 2888 ± 331 mg x min/dL; a difference of only 384 mg x min/dL. The volume of 
the drink might have an effect on glycemic response since we fed the subjects with different 
volumes of dextrose in two phases. However, according to the study of Gregersen et al., the 
volume of test meal had no effect on glycemic response (Gregersen et al., 1990). They 
showed that an increase of water volume (given as tap water) from 90 to 600 mL did not alter 
the glycemic or insulinemic responses. One difference between our study and Lee and 
Wolever’s dose-response study is that we used two completely different groups of subjects in 
Phase I and Phase II, but they fed the same group of subjects with 25 g and 50 g of glucose in 
a randomized order. Studies have shown there is a high interindividual variability of 
glycemic index value. For example, in a Vega-Lopez and colleagues’ study, when white 
bread was fed to 25 healthy subjects, the glycemic index values ranged from 44 to 132, with 
a CV of 30% (Vega-Lopez et al., 2007). Besides that, another report showed that the CV of 
the white bread AUC for subjects with type 2 diabetes was 33%, and for subjects with type 1 
diabetes it was 39% (Wolever et. al., 1987). Therefore, we concluded that the reason we did 
not see the dose-response fashion was due to the high interindividual variability.  
Both Lifeway ProBugs Kefir (orange flavor) and Lifeway® Low Fat Plain Kefir were 
more satiating than the control food; however, this difference was not significant. In terms of 
the interrelationships among glucose, insulin and satiety responses, statistically, the 
correlations between the glycemic score and satiety index or insulin index and satiety index 
were not significant. However Lifeway® Low Fat Strawberry Kefir which had the highest 
glycemic score had the lowest SI value. Both of the Lifeway ProBugs Kefir (orange flavor) 
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and Lifeway® Low Fat Plain Kefir had similar glycemic scores and so did their SI values. 
Many studies have been conducted to examine the relationship between glycemic index and 
satiety. However, the results of the studies are inconsistent. Some found no effect of GI on 
satiety and food intake, while others found a significant suppression of hunger and appetite 
after consumption of the low GI diets. A most recent review article written by Bornet et al., 
investigated 19 human studies, testing carbohydrate foods or mixed meals’ effects on satiety 
(Bornet et al., 2007). In this review article, when a subjective method of assessment was used 
in the studies, Bornet et al. showed that 12 out of 18 of the studies supported an inverse 
relationship between GI diets and satiety, which means low glycemic index food, produces 
high satiety. Moreover, when an objective method of assessment was used (ad libitum food 
intake) in the studies, four out of seven showed the similar results. In the present study, a 
variance of components analysis showed that a sample size of 12 subjects would give enough 
power to find a significant relationship between the correlated effects of the treatments on 
glycemic score and satiety index values. 
As mentioned above, the ingredient information on the food labels showed that both 
strawberry and orange-flavored kefir had added cane juice and juice concentrate, which 
might contribute to the GI value difference among three types of kefir drinks. For this reason, 
a carbohydrate analysis was performed to determine the different types of carbohydrate 
contained in the beverages. The results of this analysis showed that all three types of kefir 
contained varied amount of glucose, sucrose and lactose. By using the GI mixed meals 
calculation method introduced by Wolever and Jenkins (1986), we proceeded to predict the 
GI values of each type of kefir with the data obtained from the carbohydrate analysis. From 
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the calculation, we were able to show that there was no significant difference between the 
actual and the predicted GI value of the beverages.   
In addition, the results of Phase III in our study showed dissociation between the GI 
and II of kefir. Even though the GI values for all Lifeway®  kefir beverages were significantly 
lower than the control, their insulinemic responses were not. The insulinemic responses of all 
three type of kefir were not significantly different from those for the white bread (control). In 
fact, all of the II values for kefir drinks exceeded the control as shown by Table 7. Therefore, 
the finding of our study is in agreement with the results of Ostman et al. (2001). In Ostman 
and colleagues’ study, they tested one type of regular milk and two types of fermented milk: 
ropy milk and filmjolk by using white bread as the standard. The GI values for all three milk 
products were very low (GI = 15 to 30); however, the II values were very high relative to 
their GIs (reported to be similar with the reference meal’s value). In this study, they also 
tested the GI and II for lactose solution. The results showed that GI of lactose correlated very 
well with its II value, suggesting that some milk components, but not lactose content can 
stimulate insulin secretion. Prior to the study of Ostman et al., inconsistency between GI and 
II of milk products had been noted in Gannon and colleagues’ study when 50 g carbohydrate 
of skim milk were given to seven subjects with type 2 diabetes,  ages 64±3 years, and with 
BMI of 32.2±1.7 kg/m²  (Gannon et al., 1986). Lijeberg and Bjorck’s study also confirmed 
the findings of Ostman et al. by supplementing milk to a high-GI white bread and a low-GI 
spaghetti meal to 10 healthy volunteers (Liljeberg and Bjorck, 2001). The results of the study 
demonstrated that both bread and spaghetti had higher insulin responses when milk was 
given compared with water. The insulinotrophic effect of milk products has not been 
understood. There are many potential unexplored mechanisms for the discrepancy of GI and 
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II of milk. Two non-carbohydrate components, protein and fat in the milk, are to believe to 
be the cause of this discrepancy. However, later when Hoyt et al. (2005) studied the GI and II 
for skim milk and whole milk, they ruled out the possible insulinotropic effects of fat content 
in milk. This is because both skim and whole milk showed discrepancy of GI and II although 
their fat content was different. Most recently, Nilsson et al. (2004) and Frid et al. (2005)’s 
studies showed that the insulinotropic effect of milk is most probably related to the whey 
protein fraction of milk. The mechanism of this effect remains unknown; however, they 
proposed that whey might contain specific insulinogenic amino acids and bioactive peptides, 
either naturally present in whey or produced during digestion that can stimulate insulin 
secretion. Besides that, they also proposed that the incretin hormones, glucose-dependent 
insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) might play an 
important role because both of these hormones were significantly elevated after the ingestion 
of whey protein. All in all, further research is needed to elucidate the mechanism of the 
insulinotropic effect of whey protein in milk.  
In summary, our data from healthy male and female subjects demonstrated that 
Lifeway® Low Fat Strawberry Kefir is a medium GI food (GI = 60), and Lifeway ProBugs 
Kefir (orange flavor) (GI = 48) as well as Lifeway® Low Fat Plain Kefir (GI = 36) are low GI 
food. Therefore, potentially Lifeway® kefir could be an ideal food to recommend to patients 
with diabetes. There is a high interindividual variability in GI testing. This is because we 
could not show the dose-dependent fashion when 25 and 50 g of dextrose were fed to two 
different groups of subjects. Moreover, our data showed a slight but not significant inverse 
relationship between glycemic and satiety responses. This possibility can be further tested by 
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increasing the number of subjects. Lastly, our data showed that kefir, like other dairy 
products, showed the dissociation of GI and II. 
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TABLES: 
Table 1. The portion sizes and nutrient composition of the test foods for Phase I and II 
 
Phase I     Phase II               
Lifeway® Low Fat 
Strawberry Kefir 
ProBugs kefir, 
orange flavor    
Lifeway® Low 
Fat Plain Kefir             
 
Portion size (mL) 
 
546 
 
548   
 
667         
Available 
carbohydrate (g) 
 
50 
 
50   
 
25         
Energy (kcal)  396  481    334         
Protein (g)  32  33    39         
Fat (g)  5  19    6 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Table 2. The portion sizes and nutrient composition of the test foods for Phase III 
   
  Lifeway® Low Fat 
Strawberry Kefir 
ProBugs 
kefir, orange 
flavor 
Lifeway® 
Low Fat 
Plain Kefir 
Sara Lee® 
White 
Bread   
     
Portion size (mL)  331  273  479 
−    
Energy (kcal)  240  240  240  240     
Available 
carbohydrate (g) 
30  25  18  37 
   
Protein (g)  19  16  28  8     
Fat (g)  3  9  4  4 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Table 3. Subject characteristics of each phases¹       
Phase  Age (y)  Ethnicity  BMI (kg/m²)  Fasting plasma 
glucose level 
(mg/dL) 
I (n = 5 M, 5 F)  22 ± 2  2 Asian; 8 Caucasian  22 .2 ± 3.4  88 ± 5.6 
II (n = 5 M, 5 F)  23 ± 3  10 Caucasian  22.6 ± 3.0  91 ± 4.0 
III (n = 5 M, 5 F)  27 ± 4  2 Asian; 8 Caucasian  24.2 ± 3.4  93 ± 4.6 
              
¹ values represent means ± SD 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Table 4 . The area under the 120 min plasma glucose response curves (AUC) (mean ± SEM) for 
Phase I ¹ ² 
 
Treatments  Total glucose AUC (mg (0‐120 min)/dL)            
Lifeway® Low Fat 
Strawberry Kefir 
1929 ± 305 b 
     
 
ProBugs kefir, orange 
flavor 
1604 ± 305 b 
     
 
Reference meal  
(glucose) 
 
3272 ± 229a 
        
 
¹ Values represent means ± SEM (n=10);         
² Treatments bearing different letters were significantly different (p<0.05 level of significance) by crossover ANOVA, 
  after Tukey adjustment 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Table 5 . The area under the 120 min plasma glucose response curves (AUC) (mean ± SEM) for 
Phase II ¹ ² 
 
Treatments  Total glucose AUC (mg (0‐120 min)/dL)       
 
Lifeway® Low Fat Plain Kefir  866 ± 245 b 
   
 
Reference meal (glucose)   2888 ± 331 a 
     
 
¹ Values represent means ± SEM (n=10);       
² Treatments bearing different letters were significantly different (p<0.05 level of significance) by crossover ANOVA, 
  after Tukey adjustment 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Table 6a. The area under the 120 min plasma glucose, insulin, and satiety response 
curves (AUC) (mean ± SEM) for Phase III ¹ ² 
Treatments  Total glucose AUC 
(mg/dL min) 
Total insulin AUC 
(µIU/mL min) 
Total satiety AUC 
(RS units min) 
Lifeway® Low Fat 
Strawberry Kefir 
1530 ± 324 ab  1187 ± 270 a  107 ± 25 a 
ProBugs kefir, orange 
flavor 
1098 ± 324 b  769 ± 277 a  155 ± 25 a 
Lifeway® Low Fat Plain 
Kefir 
1116 ± 324 b  894 ± 270 a  167 ± 25 a 
Reference meal (white 
bread)  
2286 ± 288 a  1243 ± 270 a  130 ± 25 a 
¹ Values represent means ± SEM (n=10);     
² Treatments bearing different letters within the column were significantly different (p<0.05 
level of significance) by crossover ANOVA, after Tukey adjustment 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Table 6b. The glycemic scores, insulinemic index  and satiety index of Phase III ¹ ² 
 
Treatments  Glycemic score 
(%) 
Insulin index (%)  Satiety index (%) 
         
Lifeway® Low Fat 
Strawberry Kefir 
87 ± 24 a  142 ± 48 a  85 ± 19 a 
       
ProBugs kefir, orange 
flavor 
44 ± 9 a  124 ± 43 a  121 ± 27 a 
       
Lifeway® Low Fat Plain Kefir  41 ± 12 a  112 ± 36 a  122 ± 16 a 
       
Reference meal (white 
bread)  
100 ± 0 a  100 ± 0 a  100 ± 0 a 
         
¹ Values represent means ± SEM (n=10);             
² Treatments bearing different letters within the column were significantly different (p<0.05 level of  
  significance) by crossover ANOVA, after Tukey adjustment 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Table 7. Glycemic and insulinemic indexes of all Phases 1 2 3 4 
Treatments  GI     II    
   Phase I  Phase II  Phase III    
Lifeway® Low Fat 
Strawberry Kefir 
60 ± 10 b         ‐   142 ± 48 a   
ProBugs kefir, orange 
flavor 
48 ± 10 b         ‐      124 ± 43 a   
Lifeway® Low Fat Plain 
Kefir 
     ‐        36 ± 9 b  112 ± 36 a   
Reference meal  100 ± 0 a  100 ± 0 a  100 ± 0 a    
¹ Values represent means ± SEM (n=10);       
² Treatments bearing different letters were significantly different (p<0.05 level of   
  significance) within the same phase by crossover ANOVA, after Tukey adjustment   
3 Phase I and II used glucose solutions as reference, whereas Phase III used white  
   bread   
4 All the treatments were compared against 100% of the reference food 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Table 8. The different types of carbohydrate content in Lifeway® Kefir 1       
Types of 
carbohydrate (g) 
Lifeway® Low Fat 
Strawberry Kefir 2 
ProBugs kefir, 
orange flavor3 
Lifeway® Low Fat 
Plain Kefir4 
         
Glucose  13.2 ± 0.4  3.1 ± 0.1  0.1 ± 0 
       
Sucrose  0.3 ± 0.5  28.7 ± 0.6  0 ± 0 
       
Lactose  35.9 ± 0.9  35.5 ± 1.0  47.5 ± 1.4         
Total  49.5  67.3  47.6           
¹ Values represent means ± SD (n=3);             
2 Amount of glucose, sucrose and lactose were measured in 546 mL of Lifeway® Low Fat Strawberry Kefir  
3 Amount of glucose, sucrose and lactose were measured in 548 mL of Lifeway ProBugs Kefir (orange flavor)  
4 Amount of glucose, sucrose and lactose were measured in 667 mL of Lifeway® Low Fat Plain Kefir 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Table 10. The actual GI values were not significantly different compared with the predicted GI of 
Lifeway® Kefir 
  
Beverages 
Actual GI 
values 
Predicted GI 
values 
     
  
Lifeway® Low Fat 
Strawberry Kefir 
60 a  61 a     
 
ProBugs kefir, 
orange flavor 
48 a  58 a     
 
Lifeway® Low Fat 
Plain Kefir 
36 a  46 a     
 
                 
¹ T‐tests were used to test for differences between actual and predicted GI values   
² Treatments bearing different letters within the row were significantly different    
(p<0.05 level of significance) 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FIGURES: 
Figure 1. The visual analog scale used in satiety index testing. 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Figure 2. Blood glucose responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), and control (mg/dL, over 120 minutes). 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Figure 3. Blood glucose responses to Lifeway® Low Fat Plain Kefir (P group), and control (mg/dL, 
over 120 minutes). 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Figure 4. Blood insulin responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control 
(µIU/mL, over 120 minutes). 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Figure 5. Satiety responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs Kefir 
(orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control (RSU, 
over 120 minutes). 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GENERAL CONCLUSION 
 Low-GI diets have received a considerable attention due to their positive effects on 
risk factors for certain chronic diseases. In recent decades, low-GI diets became one of the 
strategies to combat obesity in this country. Studies have established that dairy products 
generally have low GI values. Kefir, a type of milk product that is commonly used in most 
Eastern Europe countries, has low GI value compared with reference meal. However, when 
sweetener is added to kefir, it can increase the GI value of this dairy product.  
 Pure carbohydrates, sugars and starchy foods have a high correlation between 
glycemic and insulinemic responses. However, certain foods can produce higher insulin 
responses than expected from their GI. Milk is one of the non-starchy foods that shows an 
insulinotropic effect. In our study, kefir is proved to have the same effect. Whey fraction of 
milk products which consists of leucine, isoleucine, valine, lysine and threonine, are believed 
to be the potent stimulators of insulin secretion.  
 Many studies have been conducted to examine the relationship between glycemic 
index and satiety; however, the results are inconsistent. Our data showed a slight but not 
significant inverse relationship between glycemic and satiety responses. We believe that if 
the number of subjects were increased, it would provide a better power to detect the 
relationship of glycemic score and satiety index value. 
 In conclusion, kefir is a medium to low GI food depending on the added sweetener. 
Therefore, kefir can potentially be a useful food choice for patients with diabetes who are 
required to control their blood glucose levels.  
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APPENDIX A. INDIVIDUAL SUBJECT CHARACTERISTICS OF ALL PHASES 
Table 11a. Individual subject characteristics of phase I 
Subject ID  Age (y)  Ethnicity  BMI (kg/m²) 
Fasting plasma 
glucose level 
(mg/dL) 
101  25  Caucasian  25.0  85 
102  20  Caucasian  22.5  99 
103  22  Asian  29.2  86 
104  21  Caucasian  22.1  93 
105  22  Caucasian  22.2  93 
106  22  Caucasian  24.9  89 
107  21  Caucasian  18.9  81 
108  23  Asian  18.9  89 
109  19  Caucasian  19.5  87 
110  22  Caucasian  18.7  81 
         
         
         
         
Table 11b. Individual subject characteristics of phase II 
Subject ID  Age (y)  Ethnicity  BMI (kg/m²) 
Fasting plasma 
glucose level 
(mg/dL) 
201  19  Caucasian  20.2  89 
202  28  Caucasian  22.8  94 
203  21  Caucasian  29.8  93 
204  26  Caucasian  20.5  87 
205  22  Caucasian  21.0  92 
206  22  Caucasian  24.2  95 
207  23  Caucasian  24.1  83 
208  23  Caucasian  20.9  95 
209  19  Caucasian  22.4  94 
210  28  Caucasian  19.9  89 
         
 
 
 
100 
Table 11c. Individual subject characteristics of phase III 
Subject ID  Age (y)  Ethnicity  BMI (kg/m²) 
Fasting plasma 
glucose level 
(mg/dL) 
301  21  Caucasian  19.0  98 
302  22  Asian  22.9  90 
303  25  Caucasian  21.2  92 
304  35  Asian  22.3  98 
305  20  Caucasian  29.2  97 
306  25  Caucasian  25.7  89 
307  27  Caucasian  27.0  86 
308  26  Caucasian  28.9  89 
309  25  Caucasian  22.4  97 
310  20  Caucasian  22.9  97 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APPENDIX B. INDIVIDUAL GLUCOSE, INSULIN AND SATIETY AUC GRAPHS 
OF ALL PHASES 
Phase I: Blood glucose responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), and two controls (glucose solutions) (mg/dL, over 120 minutes).   
Subject 101 
  
Subject 102 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Phase I: Blood glucose responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), and two controls (glucose solutions) (mg/dL, over 120 minutes).   
Subject 103 
 
Subject 104 
 
Subject 105 
 
 
103 
Phase I: Blood glucose responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), and two controls (glucose solutions) (mg/dL, over 120 minutes).   
Subject 106 
 
Subject 107 
 
Subject 108 
 
104 
Phase I: Blood glucose responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), and two controls (glucose solutions) (mg/dL, over 120 minutes).   
Subject 109 
 
Subject 110 
 
 
 
 
 
 
 
 
105 
Phase II: Blood glucose responses to Lifeway® Low Fat Plain Kefir (P group), and controls (glucose 
solutions) (mg/dL, over 120 minutes).   
 
Subject 201 
 
 
 
Subject 202 
 
Subject 203 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Phase II: Blood glucose responses to Lifeway® Low Fat Plain Kefir (P group), and controls (glucose 
solutions) (mg/dL, over 120 minutes).   
 
Subject 204 
 
 
Subject 205 
 
 
 
Subject 206 
 
 
 
 
 
107 
Phase II: Blood glucose responses to Lifeway® Low Fat Plain Kefir (P group), and controls (glucose 
solutions) (mg/dL, over 120 minutes).   
 
Subject 207 
 
 
 
Subject 208 
 
 
 
Subject 209 
 
 
 
 
 
108 
Phase II: Blood glucose responses to Lifeway® Low Fat Plain Kefir (P group), and controls (glucose 
solutions) (mg/dL, over 120 minutes).   
 
Subject 210 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Phase III:  Blood insulin responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control 
(µIU/mL, over 120 minutes).  
 
Subject 301 
 
 
 
Subject 302 
 
 
 
Subject 303 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Phase III:  Blood insulin responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control 
(µIU/mL, over 120 minutes).  
 
Subject 304 
 
 
 
Subject 305 
 
 
 
Subject 306 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Phase III:  Blood insulin responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control 
(µIU/mL, over 120 minutes).  
 
Subject 307 
 
 
 
Subject 308 
 
 
 
Subject 309 
 
 
 
 
112 
Phase III:  Blood insulin responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs 
Kefir (orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control 
(µIU/mL, over 120 minutes).  
 
Subject 310 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Phase III: Satiety responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs Kefir 
(orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control (RSU, 
over 120 minutes).   
 
Subject 301 
 
 
 
Subject 302 
 
 
 
Subject 303 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Phase III: Satiety responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs Kefir 
(orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control (RSU, 
over 120 minutes).   
 
Subject 304 
 
 
 
Subject 305 
 
 
 
Subject 306 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Phase III: Satiety responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs Kefir 
(orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control (RSU, 
over 120 minutes).   
 
Subject 307 
 
 
 
Subject 308 
 
 
 
Subject 309 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Phase III: Satiety responses to Lifeway® Low Fat Strawberry Kefir (S group), Lifeway ProBugs Kefir 
(orange flavor) (O group), Lifeway® Low Fat Plain Kefir (P group), and white bread control (RSU, 
over 120 minutes).   
 
Subject 310 
 
 
 
